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SUMMARY
How GABAA receptor subtypes segregate so precisely to different subcellular
locations is not understood. In this study, I have expressed the recombinant g2
and d GABAA receptor subunits in cultured hippocampal neurons to analyze the
differential cell surface expression and sub-membrane segregation of synaptic
and extrasynaptic GABAA receptors.  My data demonstrate that the synaptic
targeting of g2-containing GABAA receptors does not depend on the cytoplasmic
TM3-TM4 domain of the g2 subunit. This result was actually surprising, until
Alldred et al published their work last year (2005) showing that the synaptic
localization of receptors with the g2 subunit requires the TM4 domain rather
than the large TM3-TM4 cytoplasmic loop. The premise of our work, when we
started, was that the loop region would be responsible. On the other hand, I
showed here that the TM3-TM4 cytoplasmic domain of the d subunit is either a
factor for the extra-synaptic clustering of the d containing GABAA receptors
(this would be an active mechanism) or alternatively that this loop region may
not contain any information at all on receptor targeting, and subunits with this
domain may simply lack sufficient “information” to be placed in synapses
(passive exclusion). I cannot currently distinguish between these two
possibilities. Nevertheless, by comparing the d subunit TM3-TM4 loop amino
acid sequences across the whole span of vertebrate evolution, I discovered that
the loop was remarkably conserved. This would suggest that the loop’s tertiary
structure and specific proteins that bind to it are important for some function(s)
of d-containing receptors. A passive exclusion mechanism might have lead to a
degeneration of the loop sequence.
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ZUSAMMENFASSUNG
Wie GABAA-Rezeptor-Untereinheiten so präzise an verschiedene subzelluläre
Orte verbracht werden, ist nicht vollständig verstanden. In der vorliegenden
Arbeit habe ich rekombinante g2- bzw. d-Untereinheiten des GABAA-Rezeptors
in kultivierten hippokampalen Neuronen exprimiert, um die unterschiedliche
Expression an der Zelloberfläche und die Verteilung über verschiedene
Membrankompartimente von synaptischen und extrasynaptischen GABAA-
Rezeptoren zu analysieren. Meine Ergebnisse zeigen, dass die synaptische
Lokalisierung von GABAA-Rezeptoren, die g2-Untereinheit enthalten, nicht von
der zytoplasmatischen TM3-TM4 Domäne der g2-Untereinheit abhängt. Dieser
Befund war in der Tat überraschend, bis Alldred et al. letztes Jahr (2005)
publizierten, dass die synaptische Lokalisation des Rezeptors mit einer
g2-Untereinheit eher von der TM4 Domäne abhängt als von der
zytoplasmatischen TM3-TM4 Domäne. Unsere anfängliche Arbeitshypothese
hingegen war, dass die zytoplasmatische Schleifenregion für die Lokalisation
verantwortlich ist. Auf der anderen Seite konnte ich zeigen, dass die
zytoplasmatische TM3-TM4 Domäne der d-Untereinheit eine Rolle für die
extrasynaptische Lokalisation von GABAA-Rezeptoren mit d -Untereinheit spielt
(dies bedeutete einen aktiven Mechanismus) oder alternativ, dass diese
Schleifenregion keine Information bezüglich der Lokalisation des Rezeptors
enthält und Untereinheiten mit dieser Domäne mangels fehlender Information
nicht in Synapsen lokalisiert werden (passiver Ausschluss). Welcher
Mechanismus vorliegt, kann auf Grundlage der vorliegenden Daten nicht
entschieden werden. Eine Analyse der Aminosäuresequenz der
zytoplasmatischen TM3-TM4 Domäne der d-Untereinheit zeigt, dass diese über
verschiedene Spezies hinweg hochgradig konserviert ist. Dies legt nahe, dass die
Tertiärstruktur und spezifische Proteine, die mit dieser Schleifenregion
interagieren, eine wichtige Rolle für die Funktion von GABAA-Rezeptoren mit
d-Untereinheit spielen. Ein passiver Ausschluss hingegen hätte wohl eine
Degeneration der Schleifensequenz erlaubt.
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1. Introduction and overview
1
1 INTRODUCTION AND OVERVIEW
Brain information processing depends on appropriately integrating excitatory and
inhibitory neural inputs as circuits (Fried et al., 2002; Schummers et al., 2002;
Koch et al., 1983). Synapses are the specialized subcellular structures by which
the majority of these signals between central neurons are transmitted via the
“fast” transmitters glutamate, GABA, and glycine. For glutamatergic synapses,
the postsynaptic neuron harbors an electron-dense meshwork of proteins that
form a complex apparatus of sub-synaptic scaffold, which, based on its
appearance in electronmicrographs (em), is called a postsynaptic density (PSD).
The PSD provides the framework for the clusters of specific glutamate-gated
neurotransmitter receptors, as well as for the voltage-gated ion channels and
diverse second messenger signalling molecules concentrated at postsynaptic
membranes precisely matching with the active zone of the presynaptic bouton,
which contains the specialized assembly for the neurotransmitter release upon a
depolarising action potential (reviewed by Waites et al., 2005). Unlike
glutamatergic synapses, the potsynaptic areas of GABAergic synapses are not
marked by any electron dense zones in em; thus GABAergic synapses are termed
“symmetrical”.
The formation, maturation and elimination of both GABAergic and glutamatergic
synapses (synaptogenesis) is essential for the integrity of neural networks. Any
alterations during this process can cause cognitive disorders (Zoghbi, 2003).
Moreover, the molecular basis of learning and memory is believed to be synaptic
plasticity, which requires bi-directional regulation of pre- and postsynaptic
boutons both structurally and functionally (Chklovskii, 2004). A defining event
during synaptogenesis is the formation of neurotransmitter receptor clusters in
distinct domains of the postsynaptic membrane. Therefore clustering of
neurotransmitter receptors on the postsynaptic membrnane arises as a theme in
order to understand the molecular mechanisms governing the neural networks
and synaptic plasticity. On the other hand, neurotransmitter receptors are not only
clustered in the postsynaptic membrane. They also form nonsynaptic clusters
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with diverse structural and functional properties in specific sub-membrane
domains of dendritic tree, somatic and axonal segments, providing distinct
signalling gateways. Moreover, diversity and dynamics of these gateways is a
prominent factor that provides single neurons great computational power
(Hausser et al., 2000). With this way, even simple types of input signals can
processed for further refinement. For example, cerebellar granule cells, at their
distal dendritic arbors, are innervated by Golgi cells, which are the only
inhibitory input source. Yet these cells express at least two GABA receptor
subtypes located in specific domains of the plasma membrane (Jones et al., 1997;
Brickley et al., 2001). One of these receptor subtypes, the synaptic GABAA
receptors, are massively clustered at the postsynaptic membrane, besides to other
sub-membrane regions and responsible for the phasic inhibition which is the
classical fast response to pre-synaptic GABA release. On the other hand another
receptor subtype is only located at extrasynaptic sites. These extrasynaptic
receptors have higher affinity for GABA and mediate a different form of
GABAergic inhibition called tonic inhibition. Tonic inhibition sets the threshold
for the action potential generation (Hausser and Clark, 1997) and shunts the
excitatory synaptic inputs (Hamann, et al., 2002). To perform these tasks
correctly, the synaptic and extrasynaptic receptors must be sorted, targeted and
clustered precisely on the required membrane compartments. Therefore the
formation and maintenance of these distinct clusters must be mediated by
regulated trafficking of these receptors, a phenomenon not well understood.  My
thesis study concerns the clustering of GABAA receptors on the distinct
subdomains of plasma membrane by focusing on two groups of GABAA receptor
subtypes: g2-containing GABAA receptors (g2-GABAAR) and d-containing
GABAA receptors (d-GABAAR).
1.1 GABAA receptors
GABAA receptors are GABA-gated anion channels responsible (together with
ligand-gated glycine receptors) for most fast inhibitory synaptic transmission in
the vertebrate central nervous system. GABAA receptors are permeable to HCO3-
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and Cl- ions; the permeability ratio of HCO3-/Cl- is approximately 0.2 to 0.4
(reviewed in Kaila et al., 1997). HCO3- moves out of the cell causing a mild
depolarization (the reversal potential for HCO3- is –12 mV). In mature neurons
Cl- usually moves into the cell overriding this mild depolarization, causing a
strong inhibitory hyperpolarization as the Cl- reversal potential is 15-20 mV more
negative than the resting membrane potential. The Cl- gradient is maintained by
K-Cl co-transporters (Rivera et al., 2005). Depending on the intracellular Cl-
concentration, GABAA receptor activation can also lead to Cl- efflux and
depolarization. This is the case, for example, during embryonic and early
postnatal development when K-Cl cotransporters are not expressed at sufficient
levels to efficiently transport Cl- out of the cell (Rivera et al., 2005). There are
interesting caveats: adult dopaminergic neurons in the substantia nigra pars
compacta have little KCC2 expression (Gulacsi et al., 2003), possibly explaining
the relatively low efficacy of GABAA receptor-mediated inhibition in nigral
dopaminergic neurons (Gulasci et al., 2003). Further, KCC2 expression can vary
in subdomains of neurons, thus affecting local Cl- gradients. KCC2 is absent from
the axon initial segments of neocortical pyramidal cells (Szabadics et al., 2006).
Thus GABAergic terminals arriving at this location may produce depolarization
via GABAA receptors in this context. In hippocampal neurons the dendritic
KCC2 channels can also be transiently inhibited by Ca2+ entry through voltage-
gated Ca2+ channels, thus producing local changes in the dendritic Cl- gradient,
and affecting the efficacy of GABAA receptor inhibition and possibly inducing
plasticity at GABAergic synapses (Fiumelli et al., 2005). This is a potential
mechanism to bear in mind when considering GABAergic function for example
in the basal ganglia.
1.1.1 GABAA receptors: genes
In mammals, GABAA receptors form as heteropentameric assemblies from a
family of 19 subunits encoded by distinct genes (a1-a6, b1-b3, g1-g3, d, e, q,
p and r1-r3) (Korpi et al., 2002a; Rudolph and Mohler, 2006; Whiting, 2006).
Depending on the subunit composition GABAA receptors differ in their
1. Introduction and overview
4
biophysical properties and affinity for GABA (see section 1.1.7 GABAA
receptors: how subunit combinations affect synaptic and extrasynaptic
transmission”), their pharmacology (see section 1.1.8 GABAA receptor agonists,
antagonists and allosteric modulators) and location on the cell (see section 1.1.6
Extrasynaptic GABAA receptors: a4bd subtype). Along with the closely related
glycine receptors, GABAA receptors were originally cloned by the classical tour-
de-force method: peptide sequences obtained from purified (bovine brain)
receptors were used to construct synthetic DNA probes to screen brain cDNA
libraries (Schofield et al., 1987; Grenningloh et al., 1987). This was the starting
point. Within a few years, this now historical technique of screening cDNA
libraries had revealed most of the gene family, all the a1-6, b1-3, g1-3 subunits
and one d subunit (Seeburg et al., 1990); over the remaining decade, a few more
subunits, such as e, q and p were characterized (Davies et al., 1997; Hedblom and
Kirkness, 1997; Bonnert et al., 1999; Sinkkonen et al., 2000). With the
completion of the human genome database, Simon and colleagues did an in silico
hybridization screen, searching for further undescribed mammalian GABAA
receptor genes but found none.  Most of the subunit gene family members are in
clusters (Simon et al., 2004), suggesting gene and then cluster duplication during
the evolutionary origin of vertebrates: b2, a6, a1, g2 form a cluster in that order
on human chromosome 5q34; the b3, a5, g3 genes cluster in that order on human
chromosome 15q13; the g 1 , a 2 , a4 , b1  genes cluster in that order on
chromosome 4p12; the e, a3, q genes in that order on X q28; the r1 and r2
genes, 40 Kb apart on 6 q15; the p, r3 and d subunit genes are isolated on human
chromosomes 5q35.1, 3q12.1 and 1p36.3 respectively (Simon et al., 2004). The
complete genome data makes it an easy task to see the gene cluster organizations
at a few keyboard strokes (http://www.ensembl.org/Homo_sapiens/index.html).
As determined by both in situ hybridization (mRNA localization) with gene-
specific probes and immunocytochemistry (protein localization) with subunit-
specific antibodies, the expression of the individual subunit genes is age- and
region-specific (Wisden et al., 1992; Laurie et al., 1992a, b; Fritschy and Mohler,
1995; Schwarzer et al., 2001). Some GABAA receptor subunit genes have
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extremely restricted expression patterns; the a6 subunit gene expresses only in
cerebellar and cochlear nucleus granule cells (Lueddens et al., 1990) the r
subunit genes are mainly expressed in retina, with low transcript levels in the
hippocampus and colliculi – these receptors, because of their unique
pharmacology, used to be termed “GABAC”; the p  gene is expressed in non-
neural tissues (Hedblom and Kirkness, 1997). The e and q subunit genes are
mainly transcribed in the locus ceruleus (the adrenergic nucleus in the brainstem),
dorsal raphe (serotinergic cells) and cholinergic cells (Sinkkonen et al., 2000;
Moragues et al., 2002).
The clustering of the
GABAA receptor subunit
genes raises the question
of whether the clustered
genes are co-regulated.
The a1 and b2 genes do
indeed share identical
transcription patterns,
nucleus for nucleus and
even have the same RNA
levels in each area
(Wisden et al., 1992;
Duncan et al., 1995);
thus these two genes may
share regulatory elements. All the other subunit genes have sometimes common,
sometimes divergent expression patterns, with no correlation with which gene is
in which cluster (Wisden et al 1992).
Figure 1.1: Predicted topology of a GABAA receptor subunit.
The cysteine disulfide bridge in the N-terminus is indicated by
a black bar. Transmembrane domains are shown as open boxes
labelled TM1-4.
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1.1.2 GABAA receptor structure
The GABAA receptor belongs to a
superfamily of ligand-gated ion
channels (“Cys-loop receptors”) that in
vertebrates includes the nicotinic
acetylcholine receptors (nAChR), the 5-
hydroxytryptamine type 3 (5-HT3)
receptors, the zinc-activated ion
channel (ZAC) and the glycine
receptors (GlyR) (reviewed in Cromer
et al., 2002; Lester et al., 2004; Peters
et al., 2005; Unwin, 2005; Sine &
Engel, 2006) (see Figure 1.1 for a
schematic showing one individual
subunit situated in the membrane). In
imagining how the GABAA receptor
must look, I can do no better than quote
Unwin 2005 for his empirical
observations on the Torpedo nicotinic
acetylcholine receptor: “The receptor (a
large 290 kDa glycoprotein) is
composed of elongated subunits, which
associate with their long axes
approximately normal to the membrane,
creating a continuous wall around the
central ion-conducting path. The whole
assembly presents a rounded, nearly 5-
fold symmetric assembly when viewed
from the synaptic cleft, but is wedge-
shaped when viewed parallel with the
membrane plane. The subunits of the receptor all have a similar size 30 Å x 40Å
Figure 1.2: Structural model of the
acetylcholine receptor from the Torpedo
electric organ. Ribbon representation of the
receptor was generated using coordinates
deposited in the Protein Data Bank (code
2BG9), with the _-subunits in orange and
non-_-subunits in pale blue. The outer
surface of the central vestibule is shown in
dark blue. Arrows indicate the limits of the
cell membrane. In the membrane region,
the radius of the vestibule is defined
mainly by the M2 helices (re-produced
from Sine and Engel, 2006).
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x 160 Å and the same three-dimensional fold. Each subunit is a three-domain
protein and so portions the channel naturally into its ligand-binding, membrane-
spanning and intracellular parts” (Unwin, 2005; reviewed by Sine & Engel, 2006;
Figure 1.2).
In GABAA receptors, the arrangement of subunits around the channel is probably
gbaba counterclockwise when viewed from the extracellular space (Baumann et
al., 2002). Current thinking is that for those cells in which they are expressed, e
and p subunits can replace the g and d subunit within the pentamer, whereas the
q subunit might replace a b subunit (Sieghart and Sperk, 2002). As for all
members of the nicotinic receptor superfamily, all GABAA receptor subunits
contain a large extracellular N-terminal domain of approximately 200 amino
acids shaped by a cysteine disulfide bridge (the so-called “Cys-loop”). For
GABAA subunits, the amino acid consensus sequence of the Cys-loop is
C******F/YP*D***C*****S (where * is a degenerate residue; Simon et al
2004). Each subunit contains four predicted transmembrane spanning domains
(TM1 to TM4) of about 20 amino acids and a large intracellular loop between
TM3 and TM4 (TM3-TM4 loop) (Figure 1) (Macdonald and Haas, 2000). Many
GABAA receptor subunits have the amino acid sequence (TTVLTMTT) in the
TM2 domain (Seeburg et al., 1990). Five of these eight amino acids have been
proposed to line the ion channel. TM1, TM3 and TM4 segregate TM2 from
membrane lipid (Unwin, 2005). The amino acids specifying that the nicotinic
receptors gate cations have been identified. The selectivity filter and gate lies at
the intracellular end of the TM2 domains and includes part of the TM1–TM2
loop. Mutating these amino acids in the a7 subunit of homomeric nicotinic
receptors produced acetycholine-gated anion channels (Galzi et al., 1992). The
converse can also be done: mutation of five amino acids in the TM1–TM2 loop
of the GABAA receptor b3 subunit to the corresponding amino acids of the a7
nicotinic acetylcholine subunit produces cation-selective GABAA receptors
(Jensen et al., 2002). Similar mutations in the a2 or g2 subunits did not change
ion selectivity. Thus the b subunits predominantly determine the ion selectivity of
the GABAA receptor (Jensen et al., 2002).
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In the 5-HT3 and nAChRs, residues in the TM3-TM4 loop region influence single
channel conductance (Peters et al., 2005; Hales et al., 2006). The TM3-TM4
loop, which may be relatively unstructured in the nAChR (Kukhtina et al., 2005),
contributes key sites for attaching anchor and regulatory proteins involved in
locating the receptor at synapses and in governing the activity of GABAA
receptors (Kittler and Moss, 2003) (see sections 1.1.5, “Synaptic GABAA
receptors: abg subunit combinations and anchoring role of the g2 subunit and
gephyrin” and 1.1.8.7 “Regulation of GABAA receptor function by
neuromodulators: the role of kinases and phosphatases”). But the TM4 region of
the g2 subunit is necessary and sufficient to confer a synaptic localization on the
receptor (Alldred et al., 2005).
The atomic structure of a GABAA receptor subunit complex has not so far been
solved directly. Instead, realistic models have used the empirically determined
structural coordinates of the muscle nicotinic acetylcholine receptor from the
electric organ of the Torpedo ray fish and a related snail acetylcholine receptor
binding protein (AChBP)  (Brejc et al., 2001; Cromer et al., 2002; Ernst et al.,
2003; Unwin, 2003, 2005; Sine and Engel, 2006). The AChBP shows sequence
similarity with the N-terminus of the nAChR at regions that build the agonist
binding sites; the AChBP contains a Cys-loop but lacks the transmembrane
domains. It assembles as soluble homopentamers (Brejc et al., 2001). The crystal
structure of the AChBP, with bound ligand, provided a template for comparative
modelling of the N-terminal extracellular domain of GABAA receptors (Ernst et
al., 2003), whereas Unwin’s most recent structure of the Torpedo nAChR at 4 Å
resolution obtained by cryo-em, and incorporating insights from the AChBP,  has
given a full scale atomic model (Protein Data Bank Code 2BG9; see Figure 1.2).
According to Xiu  and colleagues, 2BG9 represents a substantial advance for the
field, and all modern attempts to obtain molecular scale information on the
structure and function of Cys-loop receptors must consider this as a starting point
(Xiu et al., 2005; Unwin, 2005; Sine & Engel, 2006).  2BG9 provides us with a
view of how the entire GABAA receptor must look, including the transmembrane
and large cytoplasmic loops (Unwin, 2003, 2005).
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Before 2BG9, modellers used family conservation patterns and fold predictions
to estimated that 60-75% of the amino acid residues of the GABAA receptor
subunits have structural equivalents in the AChBP template (Ernst et al., 2003).
The accuracy of the GABAA receptor model will be limited in regions where
alignment is unclear (e.g due to low sequence identity) or in regions where the
AChBP differs from other family members due to its soluble, non-membrane-
bound nature (Ernst et al., 2003). A model of the extracellular domain of a
pentameric GABAA receptor consisting of two a, two b and one g2 subunit is
shown in (Figure 1.3). In this model the amino acids known to contribute to
ligand binding sites and interfaces are correctly positioned and the interface-
forming segments and the solvent accessibility of individual residues correlate
well with experimental data (Ernst et al., 2003). Six “loops” (loop A, B, C for the
plus side and D, E, F for the minus side) at the interface between neighbouring
subunits form the ligand binding sites (Sigel and Buhr 1997; Olsen et al 2004).
The binding pocket for GABA forms at the interface between the a and the b
subunit (Figure 1.3a, c and d), the binding pocket for benzodiazepines lies at the
interface of the a and the g subunit (Figure 1.3a and b). The predicted space for
agonist binding is formed by loops A, B, C, D and E (blue volume in Figure 1.3d)
and correlates with experimental data from photolabeling of a1F64 by
[3H]muscimol and substituted cysteine accessibility mapping (Ernst et al., 2003;
Olsen et al., 2004).Amino-acid residues on loops A, B, C, D and E at the
interface of the a and the g subunit influence binding, potency and efficacy of
benzodiazepines (see section 1.1.8.1 GABAA receptors: allosteric modulation by
benzodiazepines and related ligands) (Figure 1.3b) (Ernst et al., 2003). The
predicted benzodiazepine pocket is larger than the GABA pocket. It
communicates with the Cys-loop of the a subunit and extends down to the
membrane-near part, which possibly contains side chains from the linker between
transmembrane region 2 and 3 of the a subunit (Ernst et al., 2003).
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1.1.3 GABAA receptor gating by agonist
As for all other ligand-gated channels, GABAA receptors convert chemical
messages into electrical signals. In less than a millisecond, the binding of two
(tiny) molecules of GABA between the a  and b  subunits induces a
conformational change in the (giant) receptor oligomer that opens the central ion
channel (see Baumann et al., 2003). This remarkable process is called “gating”.
In the opinion of Xiu and colleagues “the gating mechanism for the Cys-loop
superfamily is one of the most challenging questions in molecular neuroscience”.
The full 2BG9 model of the nAChR suggests ways in which the agonist-binding
site couples to the transmembrane region and initiates gating; principles applying
to the nAChR are likely to apply, with minor variations, to other members of the
superfamily (Unwin, 2005; Sine & Engel, 2006). The basis for a model of how
gating works, is that specific ion pairs exert precise control over gating (Kash et
al., 2003; Xiu et al., 2005). The membrane-near location of two flexible loops,
loop 2 and loop 7 (the Cys-loop) in the crystal structure of the AChBP suggested
an involvement in gating of the Cys-loop in the GABAA receptor. Indeed, Kash
and colleges using an “ion pair model”, found by site-directed mutagenesis in the
a1 subunit that optimal gating needs electrostatic interactions between negatively
charged residues in loops 2 and 7 (Asp57 and Asp 149) and a positively charged
residue in the region linking transmembrane domains 2 and 3 (Lys 279) (Kash et
al., 2003). For the b2 subunit of the GABAA receptor the interaction between an
acidic residue in loop 7 (Asp 146) and a basic residue in pre-transmembrane
domain-1 (Lys 215) helps couple agonist binding to channel gating (Kash et al.,
2004). Studies on other members of the “Cys-loop” family found residues at
corresponding regions in the nicotinic acetylcholine receptor and the serotonin 5-
HT3 receptor as critical coupling elements for gating (Lee and Sine, 2005:
Lummis et al., 2005). Nevertheless, building on the results of Kash and
colleagues in a detailed and broad examination of electrostatic interactions in the
subunits, Xiu and colleagues concluded that no specific ion pair interaction in
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Figure 1.3: Model of the extracellular domains of a pentameric GABAA receptor consisting of 2
a , 2 b  and 1 g2 subunit. (a) View from the extracellular space. GABA binds to the interface
between the a and the b subunit, benzodiazepines bind to the interface between the a and the
g2 subunit. (b) Predicted benzodiazepine-binding pocket between the a and the g2 subunit, viewed
from the side. The binding site loops are labelled A to G. (c) and (d) The a and b subunit viewed
from the side. Loops A, B, C, D and E form the predicted GABA-binding pocket (blue volume in
(d). (reproduced from Ernst et al., 2003).
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fact influences gating, but instead a cluster of charges is important; specific ion
pair interactions are nonessential, and it is misleading to focus only on specific
residues: “Receptors have evolved to create a compatible collection of charged
residues that allows the receptor to assemble and also facilitates the existence of
and interconversions among multiple states” (Xiu et al., 2005).
1.1.4 Subunit assembly rules for GABAA receptors
The GABAA receptor subunit combinations found in brain are partly governed by
which cell types express which genes (e.g. Wisden et al., 1992) and partly by
preferential partnering of subunits within a given cell (e.g. Jones et al., 1997); for
example, the a4 and a6 subunits assemble preferentially with the d subunit
(Jones et al., 1997; Peng et al., 2002).
Figure 1.4: Molecular composition of most abundant GABAA receptors and some of
pharmacologically active zones. In the brain most of the GABAA receptors are composed of 2a,
2b, and g2 subunit. Each subunit has 4 transmembrane domains, where the internal channel pore
for the passage of Cl- ions is represented by green. 2 GABA molecules (yellow) bind on the b
subunits at the interface with the a subunit and causes the channel pore to open. Zolpidem
binding site (blue arrow) and b-carboline binding site (red arrow) is located in between the a and
g2 subunit. On the bottom of the figure, schematic representation for the effect of zolpidem (red
line) and b-carboline (blue line) on the inhibitory action of GABA (black line) is shown.
1. Introduction and overview
13
The majority of mammalian brain GABAA receptors are probably
abg2 combinations. The subunit ratio is probably 2a/2b/1g (Ernst et al., 2003)
(Figure 1.4). Some receptors also contain different a  and b subunits e.g.
a1a2b2g2 (Benke et al., 2004). According to Benke et al., 2004, who analysed
whole mouse brain samples, the a1a1bg2 combination is the most abundant
GABAA receptor subtype in the brain (61% of total). Other combinations were
found in smaller quantities: a1a2 bg2 (13%), a1a3bg2 (15%), a2a2bg2 (12%),
a2a3bg2 (2%), and a3a3bg2 (4%). Within the a 1-containing receptor
population most receptors are a1a1bg2, whereas in the a2- and a3-containing
receptor populations, receptors with two different a subunit types predominate
(Benke et al., 2004). Of course, these percentages are from homogenized brain;
within particular cell types, some of these rare subtypes will be the most
important receptor subtype.
1.1.4.1 Expression of GABAA receptor subunit genes in the vertebrate brain
GABAA receptor expression has been mapped by ligand autoradiography (e.g.
Niddam et al., 1987; Faul and Villiger, 1988; Olsen et al., 1990; Duncan et al.,
1995; Waldvogel et al., 1999; Korpi et al., 2002a), in situ hybridization with
gene-specific probes (e.g. Wisden et al., 1992; Laurie et al., 1992; Persohn et al.,
1992; Petri et al., 2002), single-cell PCR (e.g. Criswell et al., 1997; Guyon et al.,
1999; Okada et al., 2004), and immunocytochemistry with subunit-specific
antibodies at the light and electron microscopic level (e.g. Fritschy and Mohler,
1995; Somogyi et al., 1996; Pirker et al., 2000; Fujiyama et al., 2000, 2002;
Schwarzer et al., 2001).
1.1.4.1.1 Autoradiography of GABAA receptors
Ligand-autoradiography, although usually lacking cellular resolution, serves as a
highly useful indicator of which abg2 subunit combination is present in a brain
region (Korpi et al., 2002a), and is also a superbly quantitative technique (Korpi
et al., 2002a). For example, the ligand [3H]flunitrazepam is incubated with a
1. Introduction and overview
14
brain section in the absence or presence of the discriminating ligand CL218,872.
If the binding signal is reduced or even completely vanishes by co-incubation
with CL218, 872 (which has high affinity for a1bg2 receptors and so displaces
[3H]flunitrazepam), then this is a “BZI region”. If CL218,872 fails to displace
[3H]flunitrazepam, then this is a “BZII region” (reviewed in Niddam et al., 1987).
Thus BZI-type binding marks a1bg2 receptors; 3H-zolpidem autoradiography on
brain sections also selectively highlights a1bg2 receptors directly (Duncan et al.,
1995; Korpi et al., 2002a). BZII-type binding marks a2, a3 and a5bg2 type
receptors (the a4bg2 receptors are not picked up by this method, as they do not
bind [3H]flunitrazepam (see section 1.1.8.1 “GABAA receptors: allosteric
modulation by benzodiazepines and related ligands”). The abg-type receptors
with g1 or g3 are not picked up by BZI and BZII screening, neither are a4bd-type
receptors. However, many novel ligands are these days available, which could be
used as autoradiographic probes.
Autoradiography with [3H]muscimol (high-affinity site), commonly assumed to
mark all GABAA receptors, selectively marks only a4bd and a6bd receptors;
mouse brain sections with no d subunit no longer give detectable [3H]muscimol
signals (Korpi et al., 2002b). Thus the [3H]muscimol autoradiographic signals
detected in many basal ganglia areas such as the striatum (Olsen et al., 1990;
Jones et al., 1997; Korpi et al., 2002b;) will originate from a4d-containing
receptors.
1.1.4.1.2 In situ hybridization and immunocytcohemistry of GABAA
receptors
In situ hybridization is used to localize mRNA in brain regions or cell types. The
radioactive version is a sensitive assay for which cell type expresses which gene;
the use of digoxygenin-labelled probes is less sensitive but permits double
labelling for multiple gene expression. There is good agreement between
different labs on the results with GABAA receptor gene expression, probably
because hybridization of nucleic acids is reasonably standardized between labs.
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The disadvantage of in situ hybridization is that no information is obtained on
protein localization on the cell, or even if the mRNA is translated. Thus
immunocytochemistry with subunit-specific antibodies gives the ultimate
biological information. However, antibodies can be problematic; Saper and
Sawchenko (2003) point out that antibodies are biological agents, not standard
chemical reagents: antibodies may bind to a wide variety of antigens other than
the one that they were raised to recognize, and there is no way to be sure that the
pattern they stain really represents that antigen. If investigating localization in the
rodent nervous system, a knockout mouse for the particular antigen is the best
control of antibody specificity (Saper and Sawchenko, 2003; Aller et al., 2005).
This has been done for some (e.g. a1, a3, a6 and d) (Jones et al., 1997; Tretter et
al., 2001; Yee et al., 2005; Kralic et al., 2006), but not all GABAA receptor
antibodies used in published papers.
1.1.5 Synaptic GABAA receptors: abg subunit combinations and anchoring
role of the g2 subunit and gephyrin
Placing GABAA receptors at synapses requires specific proteins that interact
directly or indirectly with the g subunits. For example, targeting some GABAA
receptor subtypes to GABAergic terminals involves the widely expressed
microtubule-binding protein gephyrin (Ramming et al., 2000). The best studied
brain area for this has been the hippocampus, but splice forms of gephyrin are
found throughout the basal ganglia (Ramming et al., 2000) and so the principles
of GABAA receptor targeting would be expected to be similar there. In
hippocampal neurons in vitro and in vivo, gephyrin either helps convey some
GABAA receptor subtypes to the synapse or anchors them there – this requires the
g2 subunit (Kneussel et al., 1999; Brunig et al., 2002). Without the g2 subunit no
GABAA receptors are found in synapses in the developing or adult hippocampus
(Gunther et al., 1995; Essrich et al., 1998; Schweizer et al., 2003), and without
gephyrin much reduced numbers of some synaptic GABAA receptor subtypes,
especially a2-containing, are found; some receptor clusters, especially those
containing the a1 subunit, persist in hippocampal gephyrin knockout neurons
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(Levi et al., 2004). Other g subunits can replace synaptic targeting function of g2;
in g2 knockout mice, GABAA receptors can be restored to hippocampal synapses
by expressing the g3 subunit by transgenic rescue (Baer et al., 1999; Luscher and
Keller, 2004). Some conserved sequence identity in the large TM3-TM4
intracellular loops of the g subunits may indicate binding sites for parts of the
synapse-anchoring mechanism. Distributed cysteine residues are conserved in the
g subunit large intracellular loops, but are absent from the a, b and d subunits.
Palmitoylation of these cysteine residues via a thioester bond plays some role in
targeting g subunit-containing receptors to the synapse (Luscher and Keller,
2004); in cultured hippocampal neurons, cysteine-alanine substitutions in the g2
subunit loop region interfere with expression and clustering of receptors
(Rathenberg et al., 2004). A surprising finding is that the TM4 region of the g2
subunit is also involved in synaptic targeting, possibly by interacting with lipid
rafts occurring in the synapse or by other membrane proteins (Alldred et al.,
2005). In transfected hippocampal cultures, analyses of chimeric g2/a2 subunit
constructs showed that g2 TM4 is necessary and sufficient for postsynaptic
clustering of GABAA receptors, whereas the cytoplasmic g2 subunit domains are
dispensable (Alldred et al., 2005). In contrast, both the TM3-TM4 loop and the
TM4 domain of the g2 subunit contribute to efficient recruitment of gephyrin to
postsynaptic receptor clusters and are essential for restoration of miniature IPSCs
(Alldred et al., 2005). Thus the g2 subunit TM3-TM4 cytoplasmic loop might be
needed for inserting receptors into the plasma membrane but is dispensable for
delivery of receptors to subsynaptic dendritic sites (Alldred et al., 2005).
Gephyrin does not bind the g2 receptor subunit directly. The identity of the
missing link(s) between gephyrin and GABAA receptor subunits is unknown. As
mentioned above, the targeting of g2-containing receptors to hippocampal
synapses must depend on both the a subunit and the g2 subunit. According to
some investigators a5bg2 receptors seem largely extrasynaptic and non-
colocalized with gephyrin (Crestani et al., 2002), and when a6bg2 receptors
(normally only found in cerebellar granule cells) are ectopically expressed in
pyramidal cells these receptors remain extrasynaptic (Wisden et al., 2002). So it
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is not simply that a g2 subunit (or even gephyrin) guarantees a stable synaptic
placement of the GABAA receptor. In addition to gephyrin other clustering
proteins must contribute to the synaptic localization of selected GABAA receptor
subtypes (Kneussel et al., 2001).
1.1.5.1 GABAA receptor occupancy at synapses is dynamic
It is important to keep in mind that GABAA receptor expression on the surface of
neurons is dynamic; receptors rapidly recycle, and leave from or insert into the
synapse by rapid lateral diffusion and/or endo/exocytosis; a static crystalline
scaffold of GABAA receptors anchored at the synapse would seem to be the
wrong view (Kittler and Moss, 2003; Thomas et al., 2005); GABAA receptors
diffuse into a synaptic zone and are transiently “captured” by the anchoring
complex. However, for some inhibitory hippocampal synapses, a direct
relationship exists between the number of synaptic GABAA receptors and the
Figure 1.5: Phasic and tonic GABAergic inhibition. Fast synaptic (phasic)
inhibition is mediated mainly via g2 subunit-containing receptors (shown in black). d subunit-
containing receptors (shown in grey) are located peri- or extrasynaptically and are tonically
activated by GABA diffusing out of the synaptic cleft.
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strength of the synapse, but it is not clear what mechanisms maintain fixed
numbers of GABAA receptors long-term at specific synapses (reviewed by
Nusser, 1999).
As for glutamate receptors at excitatory synapses, neurons probably recycle
GABAA receptors as a strategy for setting their degree of excitability (Kittler and
Moss, 2003). GABAA receptors constitutively internalize by clathrin-dependent
endocytosis; this requires interactions between the b and g2 subunits and the AP2
adaptin complex (Kittler and Moss, 2003).
1.1.6 Extrasynaptic GABAA receptors: a4bd subtype
Besides mediating precisely timed synaptic point to point inhibition (phasic
inhibition) via g2 subunit-containing receptors, GABAA receptors can also
convey less time-locked signals. Low GABA concentrations in the extracellular
space, resulting from GABA diffusing from the synapse, can tonically activate
extrasynaptic GABAA receptors (Brickley et al., 2001; Staley and Scharfmann,
2005; Farrant and Nusser, 2005; see Figure 1.5).
This “tonic inhibition” is temporally uncoupled from the fast synaptic events,
causing a continually present background inhibitory conductance. Such
conductances alter the input resistance of the cell and thus influence synaptic
efficacy and integration; tonic extrasynaptic conductances, by increasing the
electrical leakiness of the dendritic membrane, substantially and indiscriminately
diminish the size of excitatory signals in dendrites (reviewed by Farrant and
Nusser, 2005; Staley and Scharfmann, 2005).
Receptors with the d subunit, a4bd in forebrain and a6bd in cerebellar granule
cells, are extrasynaptic; d subunits are perisynaptic (annular), localized around
the edge of synapses in hippocampal dentate granule cells, and totally
extrasynaptic on cerebellar granule cells (Nusser et al., 1998; Wei et al., 2003;
see Figures 1.6 and 1.7).
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In all regions so far tested (cerebellar granule cells, hippocampal dentate granule
cells, thalamic relay nuclei), d subunits contribute to GABAA receptors that
provide an extrasynaptic tonic conductance (Brickley et al., 2001; Stell et al.,
2003; Cope et al., 2005). For GABAA receptors containing a4bd subunits in the
basal ganglia, for example in the striatum, it is predicted that the receptors are
extrasynaptic and that their key properties are high affinity for neurotransmitter
and limited desensitization, enabling them to contribute to tonic background
conductances (see above) (Brickley et al., 2001; Semyanov et al., 2004).
Figure 1.6: Immunogold electron
microscopy of cerebellar granule cells to
show extrasynaptic GABAAR subtypes
(d-containing GABAARs). In the
postsynaptic sites of these cells, where
their dendrites (d) are innervated with
Golgi cell terminals (Gt), d subunit is
located extrasynaptically as shown by
large immunogold particles (double
arrowheads). As a negative control b2 and
b 3  subunits are labeled by small
immunogold particles located synaptically
(black arrows). (Nusser et al., 1998).
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1.1.7 GABAA receptors: how subunit combinations affect synaptic and
extrasynaptic transmission
Many factors will influence the type of inhibitory postsynaptic currents (IPSCs)
mediated by GABAA receptors: the number of GABAA receptors at the synapse;
the subunit composition of the receptors which influences the kinetics; the
Figure 1.7: Perisynaptic localization of d subunit containing GABAARs shown by electron
microscopy in the mouse dentate gyrus granule cells. Immunogold labeling of the d and a2
subunits of the GABAA receptor. Gold particles indicate the location of the subunit (A–D,
arrows) were present on or near the plasma membrane of dendrites (D) that were in contact with
axon terminals (T). Gold particles were localized primarily at perisynaptic sites, just outside or at
the outer edge of symmetric synapses (A, D, solid arrowheads). In contrast, immunogold labeling
for the a2 subunit was observed directly at symmetric synapses (E, F, solid arrowheads). No
labeling for either the d or a2 subunit was observed at asymmetric synapses on spines (A, F,
open arrowheads). Scale bars, 0.2 m. (reproduced from Wei, et al., 2003).
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phosphorylation state of the receptor; a differential modulation of synaptic and
non-synaptic receptors; the Cl- reversal potential; the GABA transient in the
synaptic cleft; a presynaptic regulation by neuromodulators (Mody and Pearce,
2004). A typical synaptic pulse of GABA is often cited as 0.3 to 1.0 mM lasting
for less than 1 ms (Mody and Pearce, 2004). Under these conditions, all synaptic
GABAA receptors will be saturated and give maximal responses. Nevertheless,
receptor subunit composition affects the single channel conductance, how fast the
receptors gate, how fast they switch off (deactivate and desensitize), how they
respond to allosteric modulators. GABA also diffuses out of the synaptic cleft,
where mM GABA concentrations are typically present (Nusser and Farrant,
2005); at these concentrations the GABA sensitivity of the receptor is critical.
The sensitivity of a1b3 and a1b3d containing receptors is significantly higher
(mean EC50 of approximately 2 µM and 3.5 µM, respectively) than that of
a1b3g2 containing receptors (mean EC50 of approximately 13 µM) (Fisher and
Macdonald, 1997). The single channel conductance of recombinant abg2 or
abd receptors lies in the range of 25-30 pS. The single channel conductance of
ab-heterodimeric channels is 11-15 pS (Fisher and Macdonald, 1997).
The transient kinetic properties of GABAA receptors depend on the subunit
composition. The time course of the GABAA receptor current is governed by
three different kinetic processes: activation, desensitization and deactivation.
During activation the current shows a rapid rise to the maximum. During this
time the agonist binds to the receptor and the channel opens. Desensitization
describes the unresponsiveness of the receptor and current decline in the
continued presence of agonist. Deactivation describes the current decline after
removal of the agonist. Current activation for recombinant a1b3 and a1b3d
receptors is slower than for a1b3g2 receptors, with mean 10% to 90% rise times
varying from 1.7 and 2.4 ms for a1b3 and a1b3d receptors and only 0.5 ms for
a1b3g2 receptors (Haas and Macdonald, 1999). The a subunit also influences the
activation rate. Recombinant a2b1g2 receptors have a more rapid activation
(10% to 90% rise time of 0.5 ms) than a1b1g2 receptors (10% to 90% rise time
of 1 ms) (Lavoie et al., 1997). Desensitization is also influenced by the subunit
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composition. Currents of recombinant a1b3 and a1b3g2 receptors desensitize
quicker and more completely than currents of a1b3d receptors (Haas and
Macdonald, 1999; see.Figure 1.8).
Thus the d  subunit reduces speed and extent of receptor desensitization (Figure
1.8). As receptors with the d subunit are primarily extrasynaptically and
perisynaptically located (Nusser et al., 1998; Wei et al., 2003), their limited
desensitization and high sensitivity to GABA might be important for their roles in
tonic background conductance (see below). a1b3g2 currents deactivate more
slowly than a1b3 or a1b3d currents, mainly due to a significantly longer slow
decay component (Haas and Macdonald, 1999). Again also the a  subunit
composition influences the kinetics. Deactivation of a2b1g2 containing receptors
is six to seven times slower than deactivation of a1b1g2 receptors (Lavoie et al.,
1997).
Figure 1.8: Electrophysiology of synaptic and extrasynaptic GABAARs. d containing receptors
(C) do not desensitize in the presence of 1mM GABA fibroblast cells transfected and patch
clamped, where as g2 containing ones (A) respond with quickly desensitizing hyperpolarizing
currents (reproduced from Haas and Macdonald, 1999).
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1.1.8 GABAA receptor agonists, antagonists and allosteric modulators
GABAA receptors display a rich pharmacology (Korpi et al., 2002a; Sieghart and
Sperk, 2002; Rudolph and Mohler, 2006; Whiting 2006). Generic GABAA
receptors are selectively activated by the GABA agonist muscimol, and blocked
competitively by the GABA antagonists bicuculline and SR95531 (receptors
assembled with r subunits are bicuculline- and barbiturate-insensitive, having
their own unique pharmacology). Picrotoxin blocks GABAA receptors non-
competitively, probably by binding to a site in the channel (Korpi et al., 2002a).
Many drugs bind at sites on the GABAA receptor distinct from the GABA
binding site; these drugs change the shape of the receptor oligomer so that the
efficacy of GABA at opening the channel is either increased (positive allosteric
agonists, e.g. diazepam) or decreased (negative allosteric agonists, e.g. the b-
carboline DMCM). A few allosteric modulators occur naturally in the brain (e.g.
Zn2+, neurosteroids). Generally, positive allosteric agonists are used widely in
medicine (e.g. for the induction and maintenance of general anesthesia or to treat
anxiety disorders, states of agitation, epilepsy or sleep disorders) and there is
scope to develop further these drugs to produce receptor subtype-selective drugs
with fewer side-effects (Whiting, 2006; Rudolph and Mohler, 2006); however,
negative allosteric agonists also have potential clinical applications; for example,
the drug L-655 708 works selectively at a5bg2 receptors (a subtype mainly
expressed in the hippocampus), and by decreasing GABA’s action there it acts as
a cognition enhancer (Rudolph and Mohler, 2006). A feature of all allosteric
modulators is that they usually only work when GABA is at submaximal
activating concentrations (below 1 mM), and they do not work in the absence of
GABA (with the exception of some intravenous anesthetics). Nevertheless, some
modulators (e.g. benzodiazepines) also strongly influence the deactivation rate of
the receptors even at peak synaptic GABA concentrations, and this maybe how
some of their in vivo effects originate (Mellor and Randall, 1997). In the
following sections, I briefly consider the drugs that could act on GABAA receptor
subunit combinations relevant for the basal ganglia (e.g. a1b2g2, a2b2/3g2,
a4bg2, a4bd)
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1.1.8.1 GABAA receptors: allosteric modulation by benzodiazepines and
related ligands
The main effects of benzodiazepines are sedation, anxiolysis, suppression of
seizures and muscle relaxation. These drugs require abg2-type receptors (e.g.
a1b2g2 or a2b2g2 or a3b3g2) with the drug-binding site located between the
a and g2 subunits (Ernst et al., 2003). Note a4bg2-type receptors, which could
potentially form in some nuclei of the basal ganglia, are insensitive to most BZ
drugs, as are any receptors that contain the d subunit. The substances that act at
the benzodiazepine-binding site include the classical benzodiazepines like
diazepam or flunitrazepam as well as chemically different substances like the
imidazopyridine zolpidem (relatively selective for a1bg2-type receptors).
Depending on the ligand the benzodiazepine site can mediate different effects.
Benzodiazepine antagonists like flumazenil (Ro 15-1788) inhibit the effects of
both agonists (positive allosteric modulators) and inverse agonists (negative
allosteric modulators). In clinics, flumazenil is used in cases of benzodiazepine
intoxication.
The most abundant receptor subtype in the brain, a1b2/g2 or a1b3g2,
corresponds to the pharmacologically defined BZI site with high affinity for
flumazenil (Ro 15-1788), Ro 15-4513 and flunitrazepam and selective affinity for
ligands like zolpidem (Niddam et al., 1987; Pritchett et al., 1989). Receptor
subtypes containing the a2 or a3 subunit along with b and g2 correspond to the
BZII site with high affinity for flumazenil, Ro 15-4513 and flunitrazepam but
lower affinity to zolpidem (Pritchett et al., 1989; Hadingham et al., 1993). (see
also the section 1.1.4.1.1 “Autoradiography of GABAA receptors”). The type of
b subunit has no effect on benzodiazepine pharmacology.
The BZ site is situated at the interface between the a and the g subunit (see
above; Figures 1.3 and 1.4) (Ernst et al., 2003; Ogris et al., 2004). In the a1, a2,
a3 and a5 subunits a mutation from histidine to arginine at position 101
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abolishes binding of classic agonists like diazepam (Wieland et al., 1992; Korpi
et al., 2002a). The diazepam-insensitive a4 (or a6) subunits naturally contain an
arginine residue at the homologous position, and so a4bg2 or a6bg2 receptors are
insensitive to most BZ ligands (Lueddens et al., 1990; Wisden et al., 1991; Korpi
et al., 2002a). In the g2 subunit a replacement of phenylalanine by isoleucine at
position 77 abolishes binding of zolpidem, DMCM and flumazenil whereas
flunitrazepam still shows high affinity binding (Buhr et al., 1997; Wingrove at
al., 1997; Cope et al., 2004; Ogris et al., 2004). Methionine at position 130 in the
g2 subunit is required for high affinity binding of flunitrazepam but not
flumazenil (Ro 15-1788) (Wingrove at al., 1997). The residues are distributed
over the N-terminal domains of the a and g subunits. In the assembled receptor
the residues that form the BZ binding pocket are brought into close physical
proximity by the so-called binding site “loops” (see above). It is not clear
however, whether each of the above mentioned amino acid residues really
participates in the lining of the BZ binding site or whether the inserted mutations
have allosteric effects.
1.1.8.2 GABAA receptors: allosteric modulation by intravenous anesthetics
At clinically relevant concentrations general anesthetics modulate the activity of
various ion channels (Krasowski and Harrison, 1999; Thompson and Wafford,
2001). Whereas volatile anesthetics (e.g. halothane, enflurane or isoflurane) are
positive modulators of recombinant GABAA receptors, the main targets of these
drugs in vivo are probably two pore domain (K2P) potassium channels (Franks
and Honore, 2004). The intravenous anesthetics (e.g. barbiturates, steroidal
anesthetics, propofol and etomidate) can modulate GABA’s action at the receptor
but can also activate the receptor directly in the absence of GABA at higher
concentrations (Korpi et al., 2002a). Based on the analysis of knock-in mouse
lines with propofol- and etomidate-insenstive b subunits (see below), propofol
and etomidate exert nearly all of their anesthetic actions entirely through GABAA
receptors (Rudolph and Mohler, 2004).
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The action of etomidate and propofol absolutely requires residues in TM2 and
TM3 in the b2 or b3 subunits (Jurd et al., 2003). A mutation of asparagine to
methionine at position 265 (N265M) in the 2nd transmembrane domain of the
b3 subunit abolishes the modulatory and direct effects of etomidate and propofol
in recombinant receptors (Jurd et al., 2003). A mutation of aspargine at the same
position in the b2 subunit also abolishes the action of etomidate on the GABAA
receptor (Reynolds et al., 2003). In b3(N265M) mice propofol and etomidate do
not suppress noxious-evoked movements and show a strongly decreased duration
of the loss of righting reflex, two different endpoints of anesthesia. These results
suggest that propofol and etomidate act mainly via the GABAA receptor and the
b3 subunit in particular to induce deep anesthesia. The remaining effects of
propofol and etomidate could be mediated by b2 subunit-containing receptors.
Studies on b2(N265S) mice suggested that the b2 subunit mediates the sedative
effects of etomidate whereas the b3 subunit is required for etomidate to induce a
loss of consciousness (Reynolds et al., 2003). A highly interesting issue is the
location in the brain where etomidate and propofol exert their anesthetic effects.
Is the modulation of GABAA receptors in specific nuclei required to induce
anesthesisa or do these drugs produce global effects at many GABAA receptors in
all brain circuits? In any case, as GABAA receptors with both b2 and b3 are
found throughout the basal ganglia, the operation of these nuclei will be
profoundly affected by propofol and etomidate.
1.1.8.3 GABAA receptors: allosteric modulation by neurosteroids
Neuroactive steroids modulate GABAA receptor function in many brain regions
(Belelli and Lambert, 2005; Farrant and Nusser, 2005). Naturally occurring
steroid metabolites form locally in the brain: 5a -reductase transforms
progesterone to 5a-DPH, which in turn is reduced by 3a-hydroxysteroid
oxidoreductase to allopregnanalone. Allopregnanalone potently activates GABAA
receptors. No absolute specificity of neurosteroids for particular GABAA receptor
subunit combinations exits. Many GABAA receptors are sensitive to the steroid
THDOC, but receptors with the d subunit are particularly sensitive: 30nM
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THDOC enhances the peak currents of a1b3d GABAA receptors (with 1 mM
GABA) by up to 800%; other receptor isoform currents e.g. from a1b3g2 are
enhanced to a smaller degree (5-50%) (Mihalek et al., 1999; Wohlfarth et al.,
2002; Stell et al., 2003). Thus endogenous allopregnanolone may act on
extrasynaptic abd GABAA receptors to increase basal levels of inhibition. Mice
without functional d subunits have decreased sensitivity to the sedative/hypnotic,
anxiolytic and pro-absence effects of neuroactive steroids (Mihalek et al., 1999).
1.1.8.4 GABAA receptors: allosteric modulation by Zn
2+
Zn2+ inhibits GABAA receptors (Hosie et al., 2003). In various brain regions, Zn2+
is synaptically released together with other neurotransmitters, both GABA and
glutamate (reviewed by Mathie et al., 2006). Hippocampal mossy fibres have
actually been the main area where synaptic Zn2+ actions have been investigated,
but Zn2+ is worth bearing in mind as a potential modulator of GABAergic
function in the basal ganglia. Zn2+ can reduce the amplitude, slow the rise time,
and accelerate the decay of mIPSCs. On recombinant GABAA receptors, Zn2+ has
an inhibitory potency 3400 times higher on ab receptors than on abg2 receptors
(reviewed in Hosie et al., 2003). Thus the g2 subunit lowers the sensitivity of the
GABAA receptor complex to Zn2+. Hosie et al hypothesize that in addition to its
role in promoting synaptic targeting and single channel conductance, the g2
subunit evolved to retain the fidelity of GABAergic inhibition in the presence of
Zn2+ (Hosie et al., 2003). Nevertheless, Zn2+’s potency is also a subunit- and
d subunit-dependent. The IC50 for Zn2+ inhibition of a4b3d and a4b3g2 receptors
is similar (2 mM).
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1.1.8.5 Extrasynaptic d subunit-containing GABAA receptors: allosteric
potentiation by ethanol
Blood alcohol levels of 1-3 mM can result from drinking half a glass of wine or
less. Ethanol influences many channels, including the NMDA glutamate receptor
(Hanchar et al., 2005). But amongst GABAA receptor subunit combinations, low
concentrations of ethanol (about 3 mM, a concentration six times lower than the
legal blood-alcohol limit for driving in most States in the USA) specifically
potentiate GABA responses of cloned a4bd and a6bd  receptors expressed in
Xenopus oocytes (Sundstrom-Poromaa et al., 2002; Wallner et al., 2003; Hanchar
et al., 2004, 2005). This effect is b subunit-dependent; b3 subunits provide
maximal sensitivity to ethanol (Wallner et al., 2003). Thus a glass of wine might,
via a4b3d and a6bd receptors, enhance GABAergic tonic (extrasynaptic)
inhibition in the striatum and cerebellum respectively (Hanchar et al., 2005). On
the other hand, the ethanol sensitivity of a6/d KO mice is not different from
wild-type mice (Korpi et al., 1999).
1.1.8.6 New subtype-selective drugs for GABAA receptors
GABAA receptors have always been fertile ground for drug companies. BZs,
although for many years the main stay of clinical treatments for anxiety
disorders, fell out of favour to selective serotonin reuptake inhibitors (SSRIs) due
to side effects like sedation, cognitive impairment and abuse liability. But SSRIs
are too slow acting for some situations, requiring several weeks to work. Thus
there is a medical need for fast acting anxiolytics with few/no side effects
(Whiting, 2006). To dissociate the wanted anxiolytic effects from the unwanted
side effects of GABAA agonists, two different strategies were persued: The
development of partial agonists and the development of receptor subtype specific
compounds. Despite promising preclinical assays, partial agonists (e.g.
bretazenil) so far did not meet the expectations in clinical trials. One compound
(ocinaplon) though was reported to show anxiolysis and strongly reduced
sedative side effects in Phase II clinical trials (Whiting et al., 2006). Since
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different effects of benzodiazepines are mediated by different receptor subtypes
the second strategy has focussed on the development of compounds with
selectivity for those subtypes proposed to mediate the anxiolytic effects of
benzodiazepines, that is a2 and a3 subunit containing receptors. Some of these
compounds (e.g. L-838417, TP003, SL 651498) showed a promising separation
of anxiolytic effects and side effects when tested in rodents and primates
(McKernan et al., 2000; Griebel et al., 2001, 2003; Dias et al., 2005; Rowlett et
al., 2005; Whiting, 2006). The usefulness of this second approach now has to be
evaluated in clinical trials.
1.1.8.7 Regulation of GABAA receptor function by neuromodulators: the
role of kinases and phosphatases
Many neuromodulators (e.g. dopamine) influence GABAA receptor function by
coupling their receptors to G-protein linked second messenger systems to alter
kinase and phosphatase activity (e.g. Chen et al., 2006). There has been one
intriguing report that dopamine D5 receptors directly crosslink with GABAA
receptors by using the TM3-TM4 loop of the g2 subunit (Liu et al., 2000); so far
this finding has not been followed up. More conventionally, phosphorylation is
the common way to regulate ion channels (Kitler and Moss, 2003). This is
underlined by studies on, for example, PKC e knockout mice; these mice show
increased anxiety and have impaired GABAA receptor function (Hodge et al.,
1999). For the GABAA receptor, the intracellular loops of the b  and g2 subunits
in particular are phosphorylation targets. Studies of recombinant receptors have
shown phosphorylation of these subunits by PKA, PKC, Src and PKB (Kittler
and Moss, 2003; Wang et al., 2003). Depending on the subunit phosphorylation
can have different functional effects, which might contribute to the diversity of
GABAA receptor function. For example PKA mediated phosphorylation of the b1
subunit (serine 409) leads to negative modulation of the receptor, whereas
phosphorylation of the b3 subunit (serine 408 and serine 409) enhances the
activity of GABAA receptors (Kittler and Moss, 2003). Neuromodulators that
influence GABAA receptor function via PKC include M1 muscarinic
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acetylcholine receptors, serotonin (5-HT) type 4 receptors and TrKB receptor
stimulation via BDNF (Kittler and Moss, 2003; Jovanovic et al., 2004).
Modulation of GABAA receptor function after dopamine D4 and D3 receptor
activation depends on PKA (Wang et al., 2002; Chen et al., 2006). Protein kinase
B (Akt) can phosphorylate the b2 subunit at serine 410, which promotes rapid
insertion of the GABAA receptor into the membrane, resulting in increased sIPSC
amplitudes after stimulation with insulin (Wang et al., 2003).
1.1.9 Function and physiological significance of GABAA receptor diversity
An important consequence of differences in subunit expression between cells or
differential subcellular localization of subunits within a cell is that GABAA
receptor kinetics might differ between different cells and different synapses
(Thomson et al., 2000; Nyiri et al., 2001; Freund, 2003). In the hippocampus, for
example, functionally distinct interneurons might signal via distinct GABAA
receptor subtypes (Freund, 2003).
Knockout mouse lines have been generated for many of the GABAA receptor
subunit genes (reviewed by Vicini and Ortinski, 2004). In the d subunit knockout
mice the amount of a4 subunit, which specifically co-assembles with d subunit in
the forebrain was decreased whereas the g2 subunit was upregulated. Since the
amount of the a4 subunit immunoprecipitated with g2 antibody was increased,
the remaining a4 subunit appears to more often co-assembles with g2 subunit in
the absence of d subunit. Moreover these changes were largely confined to brain
regions normally expressing the d subunit. Therefore the d subunit appears to
interfere with the co-assembly of the a4 and g2 subunits. The behavioural co-
relation of d subunit with specific functions have also been observed in the
d subunit KO mice. These include, attenuation of responses to neuroactive
steroids, reduced ethanol consumption, attenuated withdrawal from chronic
ethanol exposure and reduced anticonvulsant effect of ethanol (reviewed by
Rudolph and Mohler, 2004). Similarly, extrasynaptic a5 containing receptors
have some behavioural correlates: functional and behavioural analysis of mice
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with targeted mutations of a5 gene show that a5 deficient mice have an
enhanced learning of hippocampal dependent task (spatial learning) but no
change in anxiety response (Colinson et al, 2002).
In a beautiful series of papers, mice with specific mutations in the key H101
coding position affecting BZ sensitivity were generated in the a1, a2, a3 and a5
subunit genes and the behavioural effects of diazepam were tested (Rudolph and
Mohler, 2004). These mice have normal GABAA receptors, but in a1H101R mice
for example, only the a2bg2, a3bg2 and a5bg2-type GABAA receptors are
diazepam-sensitive. Thus by a process of subtraction, it can be deduced how
different a1bg2, a2bg2, a3bg2, and a5bg2 subtypes contribute to the diverse in
vivo pharmacological effects of diazepam and other ligands requiring the H101
site. Thus a1H101R mice no longer become sleepy when given diazepam, and so
the a1bg2 receptors are required for the sedative effects of diazepam (Rudolph
and Mohler, 2004), whereas the a2 (and a3) mediates diazepam’s anxyiolytic
effects (under the influence of diazepam a2H101R mice do not venture more into
threatening areas, whereas their wild-type littermates do) (Rudolph and Mohler,
2004). A different set of studies using a3 selective inverse agonists and agonists
also showed a significant contribution of the a3 subunit in anxyiogenesis and
anxyiolysis (Atack et al., 2005; Dias et al., 2005). The muscle relaxant activity of
diazepam is mediated by the a 2 and a3 subunits, probably because these
subunits are expressed in spinal motor neurons (Rudolph and Mohler, 2004;
Wisden et al 1991)
1.2 Aim of the study
So far I presented the accumulating data in the literature suggesting that
differentially targeted GABAA receptors are involved in specific functions during
health and disease. Therefore the molecular dissection of the mechanism
underlying the synaptic and extrasynaptic localization of GABAA receptors is
becoming very important in order to map out the molecular components of
specific behaviours mediated by synaptic and extrasynaptic GABAA receptor
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signalling. The interesting question is: how does this specific segregation of
receptor subtypes in to synaptic or extrasynaptic sites occur? More specifically,
which molecular domains could contribute to mediate this kind of differential
membrane targeting and clustering? With this present study I aim to identify
some factors involved in differential targeting of GABAA receptors in to synaptic
and extrasynaptic sites, that contribute answering this question.
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2 METHODS
2.1 DNA Constructs
2.1.1 Generation of cDNA encoding a chimeric GABAA Receptor EGFP-
tagged g 2 subunit with the d subunit TM3-TM4 loop (GFPg2-TM3-TM4d)
As a starting point, I used the plasmid pRK5GFPg2, which contains the murine
cDNA encoding g2L cDNA, tagged by EGFP as an N-terminal fusion protein in
the mammalian CMV promoter-based expression vector pRK5 (Kittler et al
2000; gift from S. J. Moss). The unique Sal I site in the polylinker of the
pRK5GFPg2 vector was first deleted by digestion with Sal I, blunting with
Klenow (see Appendix, section 5.3), and then religating to give plasmid
pRK5GFPg2DSal. Two Sal I sites (GTCGAC) were then sequentially introduced
into each end of the TM3-TM4 loop: The first one is introduced in between the
first 6th and 7th aminoacids following the TM3, i.e., in the downstream of the
HYFVSN and 83rd and 84th aminoacids, i.e., in the upstream of KMDS at the
end of the TM3-TM4 loop of the g2L subunit by site-directed mutagenesis
(Quick Change Site Directed Mutagenesis Kit, Stratagene). The Sal sites
produced in-frame additions of two amino acids (VD) at each end of the g2
TM3-TM4 loop. For the SalI site near TM3 the primers were: 5’-TAT TTT
GTC AGC AAC GTC GAC CGG AAG CCA AGC AAG-3‘ (sense) and 5’-
CTT GCT TGG CTT CCG GTC GAC GTT GCT GAC AAA ATA-3’
(antisense); for the SalI site at the 3’ end of the loop the primers were 5’-CAT
ATG CGC ATT GCC GTC GAC AAA ATG GAC TCC TAT-3‘ (sense) and
5’-ATA GGA GTC CAT TTT GTC GAC GGC AAT GCG CAT ATG-3’
(antisense). The SalI sites are underlined. The mutations were verified by
sequencing. This intermediate plasmid was termed pRK5GFPg2(Sal)2. The TM3 -
TM4 loop of the GFPg2L subunit was then removed from the pRK5GFPg2(Sal)2
plasmid by Sal I digestion and religation to give pRK5GFPg2(D-loop); this
plasmid contains a unique Sal I site permitting subsequent in-frame insertions of
other GABAA receptor subunit TM3-TM4 loops. The cDNA region encoding
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the corresponding TM3 -TM4 loop (255bp) of the mouse GABAA d  subunit
(see below) was amplified by PCR with primers, 5’-TTC AAT GCC GAC TAC
GTC GAC AGG AAG AAA CGG AAA-3’ and 5’-ATA GAT GTC GAT GGT
GTC GAC GTC TGC ATC GAT GGG-3’ flanked by Sal I sites (underlined),
cloned into pPCRsript (Stratagene), sequenced and then inserted as a Sal I
fragment into the pRK5GFPg2(D-loop) plasmid to give the final plasmid
pRK5GFPg2TM3-TM4d.
2.1.2 Generation of the cDNA encoding EGFP-tagged GABAA receptor d
subunit (GFPd)
The full-length murine GABAA d subunit cDNA was amplified by PCR (with Pfu
turbo DNA polymerase (Stratagene)) from mouse whole-brain cDNA (provided
by C. Sandu) with the following primers, flanked by EcoRI sites (underlined): 5’-
TGC CAT GAA TTC GCA ACT TTG CTT GCG CTG GGG CTA -3’; 5’-TGC
CTA GAA TTC GAG GGC CTC CAG GAG TTT GTG GCA-3’, and then
cloned into pPCRscript (Stratagene), in which the Xho I site and Sal I sites in the
vector’s multiple cloning site had been deleted in advance, to give plasmid
pScript-d. After complete sequencing to confirm that the sequence matched the
database (NCBI database accession number NM008072), the d subunit cDNA
was then sub-cloned into the CMV promoter-based pRK5 mammalian expression
vector (Aller et al, 2005) using EcoRI, to give plasmid pRK5d.
To generate an N-terminally tagged fusion protein of the d subunit with EGFP
(pRK5GFPd), I copied exactly the strategy used by Kittler et al 2000 who produced
the pRK5GFPg2 subunit vector: the EGFP reading frame was inserted between
amino acids 4 and 5 of the predicted mature N-terminus of the d subunit; during
processing in the secretary route, the signal peptide should be cleaved off, leaving
the EGFP-tagged d subunit.
An in-frame Xho I site (CTC GAG) encoding the dipeptide residues LE
(underlined) was first inserted between the fourth and fifth amino acids of the
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predicted mature d subunit reading frame (downstream of QPHH) using plasmid
pScriptd and the primers 5’-ACG CAG CCG CAC CAT CTC GAG GGC GCC
AGG GCA ATG-3’ and 5’-CAT TGC CCT GGC GCC CTC GAG ATG GTG
CGG CTG CGT-3’ (Stratagene Quickchange mutagenesis kit) to give plasmid
pScriptdDXho.
The EGFP reading frame was amplified by PCR from plasmid pEGFP-N1
(Clontech) with primers flanked by Xho I sites (underlined), with the stop codon
of the EGFP excluded at the 5’ end of the anti-sense primer: 5’-ACG TGG CTC
GAG ATG GTG AGC AAG GGC GAG GAG CTG -3’ and   5’- ATT GGA
CTC GAG CTT GTA CAG CTC GTC CAT GCC GAG-3’. The Xho 1 coding
sequences are underlined in the primers. The Xho-cut EGFP fragment was then
placed into the XhoI site of pScriptdDXho to give plasmid pScriptGFPd.  The
EGFPd insert from pScriptGFPd was then subcloned into pRK5 using EcoRI to
give plasmid pRK5GFPd.
2.1.3 Generation of cDNA encoding EGFP tagged d subunit with an
exchanged TM3-TM4 loop from the g2 subunit (GFPd TM3-TM4g2)
Two in-frame Sal I sites (each encoding VD dipeptides) were sequentially
introduced into plasmid pRK5GFPd at the end of the TM3 region (downstream of
YAFAH, 6th and 7th) and the beginning of the TM4 region (upstream of TIDI, 91
and 92) of the native d subunit reading frame by site-directed mutagenesis. The
5’ Sal I site the primers were:  5’-TTC AAT GCC GAC TAC GTC GAC AGG
AAG AAA CGG AAA-3’; and 5’-TTT CCG TTT CTT CCT GTC GAC GTA
GTC GGC ATT GAA-3’. For the second Sal I site the primers were: 5’-CCC
ATC GAT GCA GAC GTC GAC ACC ATC GAC ATC TAT-3’ and 5’-ATA
GAT GTC GAT GGT GTC GAC GTC TGC ATC GAT GGG-3’ (SalI sites are
underlined). The mutations were verified by sequencing. This intermediate
plasmid was termed pRK5GFPd(Sal)2. The TM3-TM4 loop of the GFPd subunit was
then removed from the pRK5GFPd(Sal)2 plasmid by Sal I digestion and relegation
to give pRK5GFPd(D-loop); this plasmid contains a unique Sal I site permitting
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subsequent in-frame insertions of other GABAA receptor subunit TM3-TM4
loops. The corresponding TM3-TM4 loop of GABAA g2 subunit was obtained by
Sal I digestion of pRK5GFPg2(Sal)2 (see above) and gel purification (Qiagen gel
purification kit) of the 230 bp fragment; this fragment was then ligated into
pRK5GFPd(D-loop) to give the final pRK5GFPdTM3-TM4g2 plasmid. The construct
was verified by complete sequencing.
2.1.4 Thy1 expression plasmids
The GFPg2, GFPg2TM-3TM4d, GFPd  and GFPdTM3-TM4g2 cDNAs were also all
cloned, as EcoRI fragments, into the XhoI site of the Thy1.2 expression plasmid
(Caroni, 1997) by blunting the Xho site and adding EcoRI adaptors. See
Appendix, section 5.6, for full details of Thy1 plasmid construction.
2.2 Transfection of neurons in primary culture
Hippocampal neurons at DIV7 (see Appendix, section 5.13 for details of
neuronal cell culture) in 24 well plates were transfected with the Effectene
Transfection Kit (Qiagen) using equimolar ratios of each GABAA receptor
subunit expression plasmid. The transfection mix (containing 0.4 mg DNA mix
(200 ng/ml), 60 ml EC buffer and 3.2 ml enhancer) was incubated for 10 minutes
at RT, then 6 ml Effectene reagent was added and the mixture was kept again at
RT for another 10 minutes. After this incubation, 400ml fresh neurobasal medium
was added to the transfection mix. 600 ml of the medium was removed from the
each well containing neurons DIV7, and kept aside at 37 °C for later use, and the
220 ml of transfection mix were dispersed to each well, and incubated at 37° C
5!% CO2 incubator for about 1 _ or 2 hours, after which the medium was
exchanged by a mixture of conditioned medium (60 % competent medium,
previouslly taken from each well and kept aside at 37 °C + 40 % fresh
Neurobasal medium (Gibco), -prewarmed at 37°C). Neurons were maintained in
the 37 ° C, 5!% CO2 incubator until DIV19, then processed for
immunocythochemistry.
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2.3 Immunocytochemistry on cultured neurons
Cultures were kept at 4 °C for 10 minutes, then the medium was exchanged to
PBS (137 mM NaCl, 2.7 mM KCl, 8 mM Na2HPO4, and 2 mM KH2PO4, pH 7.4)
containing 5 % NGS, and 1:10000 diluted GFP antibody (Molecular Probes), and
left for incubation for 1 hour at 4 °C without shaking. After incubation the
antibody solution was washed out by 2 times PBS for 5 minutes each.
Afterwards, the cells were fixed with 4 % Paraformaldehyde/4 % sucrose in PBS
for 10 minutes and washed for 3 times with PBS at room temperature for 5
minutes each. For membrane staining of chimeric GABAA receptors, the Alexa-
488 secondary antibody (anti-rabbit, Molecular Probes) in PBS with 5% BSA and
5% NGS was used with a concentration of 1:1000, and cells were incubated for 2
hours at room temperature. Then the cells were washed for 5 minutes three times
with PBS, and premeabilized with 0.2 % Triton PBS, for 5 minutes at room
temperature before blocking the cells with 5%BSA, 5%NGS and 0.1 % Triton.
After the blocking step, Synaptophysin, (Sigma) or GAD-67 (Chemicon)
antibodies were used as a dilution of 1:1000 for 45 minutes, 1 hour at room
temperature.  Before applying the secondary antibody Cy-3 anti-mouse (Jackson
Laboratories) with a dilution of 1:750, in the presence of 5 % BSA and 5 % NGS
for 45 munites at room temperature, cells were washed 3 times at room
temperature for 5 minutes with PBS. Finally, after rinsing the coverslips with
distilled water, the cells were mounted with Mowiol on the slides and after
overnight incubation at dark they were visualized with a laser scanning confocal
microscope.
2.4 Image acqusition and analysis
For quantitative analysis and colocalization (with synaptic markers) of chimeric
GABAA receptor clusters formed in the plasma membrane, digital microscopic
images were recorded with a 40x oil immersion objective on a Leica confocal
microscope (the confocal system is Leica TCS SP2, the microscope is a DM
IRE2 and the software is called LCS-Leica Confocal Software) and the images
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were captured with an associated CCD camera and transferred to a computer
workstation. The filter sets of the confocal microscope was, Alexa (488 nm):
500nm-535nm, Cy-3 (543 nm): 555nm-700nm. Image files were acquired with a
resolution of 1025x1025 pixels and when necessary appropriate parts of cells
were zoomed digitally under 40x objective and saved separately as tiff files. The
images recorded as tiff format were then transferred to Photoshop 4.01 (Adobe)
for the preparation of pictures of cells.
For quantification of clusters and colocalization analysis, the original data files
were directly analyzed with the Metamorph 6.01 software (Universal Imaging
Corporation). The tiff files were first background substracted by the selection of
the background area with the ‘oval’ tool, and subsequently executing the “use
region for background’ command of the software and then the files were saved
separately into another folder. The saved files were reactivated and thresholded
until the dendritic tree of neurons becomes sharpened. In order to determine the
average cluster number per 100 mm dendrite, each separately discrete object in
the images of the dendritic segments were highlighted with the “create regions
around object” tool of the software. The objects then zoomed in for a better
resolution and quantified with the “count objects manually” tool and the data
were transfered into an excel worksheet. The length of dentrite (varying in
between 50 mm to 250 mm) where the clusters were counted from the 4, 5 cells
expressing each construct, were determined by the “measure xyz axis” tool under
Apps Menu of the Metamorph software. Values were then normalized to 100 mm
and reported as (mean) ± (standard error of the mean) (SEM). The cluster sizes
were determined with the use of “integrated morphometry analysis” tool of the
same program which gives relative values. In order to quantify the colocalization
frequency of the chimeric receptors with synaptic markers, Metamorph 6.1
software was used to interactively define the chimeric GABAA receptor and GAD
or synaptophysin colocalization. The images (previously background substracted
and thresholded as described above) were analysed by ‘Measure colocalization”
tool to verify the percentage of colocalization per each condition. Data collected
with Metamorph were transferred to a Microsoft Excel worksheet for further
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evaluation. All statistical evaluations were done according to unpaired Student’s
t- test.
2.5 Determination of evolutionary conserved domains
In order to access the homologous sequences of mouse g2 and d  subunits in
vertebrates, protein sequence databases (NCBI, ENSEMBLE, Expasy) were
searched for pairwise similarity using the BLAST tool. In order to identify non-
annotated peptide sequences, genomic databases translated in six reading frames
were searched using the TBLASTN program. The BLAST programs determine
the statistical significance of local alignments produced by database searches
using the extreme value distribution statistics for a single alignment segment and
the sum statistics for two or more compatible segments. The values of the
probability (P) of obtaining an alignment with a given score by chance computed
by BLAST programs are reliable as long as regions for low complexity do not
contribute to the alignment scores (reviewed by Altschul, et al., 1994). Therefore,
a P value of 0.001 or less was considered a strong indication of homology. The
sequences were downloaded and saved as EditSeq protein files, before being
exported to MacAlign software for alignment by Clustal method (See appendix
for the accesssion number of peptide sequences used in the alignments). The
conserved domain database, provided by ENSEMBL, was searched to identify
any potentially significant motif in the intracellular domain of d subunit.
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3 RESULTS
3.1 Construction of GABAA receptor g2 and d subunit chimeras tagged with
EGFP
I first assembled the necessary cDNAs encoding N-terminally-tagged EGFP
GABAA receptor subunits in the appropriate eukaryotic expression vectors (see
the Methods section for details on how the constructs were made and Figure 3.
1). In addition to the vector backbone (described below), non-coding sequences
at the 5’ end, including the signal peptide, were amplified from 57 nucleotides
upstream of the translational start codon, and these features were kept the same in
all constructs to minimize the potential differences in expression levels. Save for
74 nucleotides downstream of the translational stop codon, all the 3’ untranslated
mRNA sequences were deleted. Using the published GFPg2 subunit as a model
(Kittler et al 2000, GFP tagged at the N terminus between amino acids 4 and 5 of
the mature peptide), I inserted an EGFP reading frame into the equivalent
position of the mouse d subunit cDNA, between amino acids 4 and 5 of the
mature peptide. Using the GFPg2 and GFPd cDNAs as templates, I used in vitro
mutagenesis, followed by “cutting and pasting” of restriction fragments to
construct two GFP-(N-terminally) tagged GABAA receptor subunit c D N A
chimeras (GFPg2TM3-TM4d and GFPdTM3-TM4g2). I subcloned all cDNAs into
mammalian expression vectors (the CMV promoter-based pRK5 and the Thy1
promoter-based vector (see Methods). I thus had a series of eight subunit cDNAs:
(Figure 1) pRK5GFPg2, Thy1GFPg2, pRK5GFPg2TM3-TM4d, Thy1GFPg2TM3-TM4d,
pRK5GFPdTM3-TM4g2, Thy1GFPdTM3-TM4g2, pRK5GFPd  and Thy1GFPd . All
constructs were completely sequenced to verify the reading frames. The next step
was to test in transfected HEK cells that the cDNAs expressed the expected full-
length proteins and that they assembled on the cell membrane (these experiments
are described in the Appendix). This was indeed the case (see Figures 5.1, 5. 2
and 5.3 in the Appendix).
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Thy 1 or CMV
Promoter
Figure 3.1: Diagram of cDNAs encoding for chimeric murine GABAA receptors subunits. The
cDNAs of GFPg2, GFPd , GFPg2d (GFPg2TM3-TM4d), GFPdg2 (GFPdTM3-TM4g2) are shown on the
right from top to bottom respectively. The corresponding protein conformations of them on the
plasma membrane is shown on the left.
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Figure 3.2: Expression of GFPg2 and GFPd in the cultured hippocampal neurons DIV19. Scanning
confocal images of immunostained hippocampal neurons DIV 19 transfected with GFPg2 (on the
top right) and GFPd (on the bottom right) subunits show that the subunits are probably co-
assemble with the endogeneos subunits, targeted to the cell membrane and form clusters, as
shown by the white arrows in the high resolution images of dentritic spines (left) of the boxed
regions (right).
GFPg2
GFPd
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3.2 GABA A receptors formed with GFPg2, GFPd, GFPg2TM3-TM4d, and
GFPdTM3-TM4g2 are targeted to the outer membrane of cultured
hippocampal neurons
As previously described by others (Kittler et al., 2000), the GFPg2 subunit when
expressed in transfected hippocampal neurons assembles into receptor clusters at
inhibitory synapses, as well as at extrasynaptic sites. This is the same result as
found for native g2 subunits (Somogyi et al 1996); thus the large N- terminal
GFP tag does not interfere with the targeting of the g2 subunit (Kittler et al,
2000).
To examine the targeting of the d subunit, I transfected the GFPd subunit cDNA
expression vector into primary cultured hippocampal neurons (see Methods and
Appendix for details). I transfected the hippocampal neurons at DIV7 and used
these neurons for immunocytochemistry at DIV 19, as the membrane targeting of
GABAA receptors are facilitated at older ages (data not shown). As a positive
control and reference I ran parallel transfections with the GFPg2 subunit cDNA
expression vector (Kittler et al 2000). It was suggested that for neurons
exogenous expression of GABAA receptors are facilitated with the co-transfection
of a1 and b2 subunits (Kittler et al 2000). As for HEK cells (Figure 5.3 in the
Appendix), neurons were triple transfected with a1, b2 and the test subunit
expression vectors. I optimized the procedure first with the GFPg2 subunit (Kittler
et al, 2001). Initial experiments were tried with the CMV promoter-based
expression vector, but I switched to an expression plasmid, which uses the
neural-specific Thy1 promoter (Caroni, 1997), and without co-transfecting the a1
and b2 subunit expression vectors, as this gave better subunit expression (data
not shown). In agreement with my findings, Christie et al (2005) also found that
cotransfection of exogenous a and b subunits is not required; they found that
expressed tagged g2 subunits in rat hippocampal neurons can coassemble with
endogenous GABAA receptor subunits and form clusters of similar density and
size to the endogenous GABAA receptor clusters, probably because the
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endogenous subunits are rate limiting for receptor assembly (Christie et al 2005).
This effect is shown in the following figures: GFPg2 (Figure 3.2), GFPg2TM3-
TM4d  (Figure 3.3), GFPd (Figure  3.2), and GFPdTM3-TM4g2 (Figure 3. 3) receptor
subunits probably co-assemble with endogenous subunits and target to the cell
membrane in cultured hippocampal neurons (most likely pyramidal neurons). For
all subunit constructs, GFP immunoreactivity of unpermeabilized cells
corresponds to the membrane targeting of subunits (see the arrows in the figures);
receptors with these tagged subunits form clusters with different sizes and
probably with different densities for each of the constructs.
3.3 GABAA receptors formed with the 
GFPg2, GFPd, GFPg2TM3-TM4d and
GFPdTM3-TM4g2 subunits have similar cluster sizes in cultured hippocampal
neurons
GABAA receptors assembled from recombinant GFPg2 and GFPd receptor subunits
expressed in hippocampal neurons form clusters that in each case have
considerable size variation, from relatively large to smaller clusters (see Table
3.1 and Figure 3.4). The comparison of relative values of cluster sizes (radius)
show that the ‘small-size’ clusters were more frequent in each case as assessed
using the ‘integrated morphometry analysis tool’ of the Metamorph 6.0 software
(see Methods for details and Figure 3.4); more than 60 % of all clusters formed
by each subunit construct at the cell surface of the neurons have a size less than
2.5 units (small clusters), at least 25% of the clusters have a size between 2.5 and
7.5 units (medium size of clusters) and rest of them have a size more than 7.5
units (large clusters, rarest form of cluster size for each case). As shown in the
Table 3.1, GFPd expressing neurons tend to form the biggest size of clusters: the
average of the maximum mean radius
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Figure 3.3: Expression of GFPg2TM3-TM4d  and GFPdTM3-TM4g2 expressed in the cultured
hippocampal neurons DIV19. Scanning confocal images of immunostained hippocampal neurons
DIV 19 transfected with GFPg2TM3-TM4d (top) or GFPdTM3-TM4g2 (bottom) subunit show that
these chimeras are most probably co-assemble with the endogeneous subunits, targeted to the cell
membrane and form clusters, as shown by the white arrows in the high resolution images (right)
of the boxed regions (left).
GFPdTM3-TM4g2
GFPg2TM3-TM4d
GFPdTM3-TM4g2
GFPg2TM3-TM4d
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Table 3.1: Cluster sizes (in relative values) for each chimeric constructs expressed in cultured
hippocampal neurons.
of the biggest clusters is 11.24 units, measured from n= 1823 clusters expressed
on 2 or more dendrites of at least 3 neurons. On the other hand the maximum
mean radius of GFPg2 clusters was relatively lower, 8.91 units (calculated from
n=1569 clusters of 2 or more dendrites of at least 3 neurons). However, as it is
seen in the Figure 3.4., the trend for the variation in cluster sizes were similar for
each of the constructs and any differences in relative cluster size for different
subunits were not statistically significant (Student’s t-test, for each case P >
0.05).
3.4 The number of clusters obtained by forming GABAA receptors with
GFPg2 in primary hippocampal neurons is more than those with GFPd 
By eye it was already clear that immunoreactivity was brightest for neurons
transfected with the GFPg2 construct, moderate in the case of GFPg2TM3-TM4d
and less for GFPd or GFPdTM3-TM4g2. Indeed, as confirmed by quantification of
cluster densities using the ‘count objects manually’ tool of the Metamorph
software, transfected neurons showed a higher degree of expression of GFPg2-
based subunits than GFPd-based subunits. By the criterion of number of puncta
Chimeric GABAARs                     Cluster size (relative values)
min max
GFPg2   <0.5 8.91
GFPg2TM3-TM4d <0.5 10.06
GFPd <0.5 11.24
GFPdTM3-TM4g2 <0.5 7.89
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GFPg2 GFPd
GFPg2TM3-TM4d GFPdTM3-TM4g2
Figure 3.4: Integrated morphometry analysis of the relative size of GABAA receptor clusters
found in hippocampal neurons transfected with either GFPg2 (n=730), GFPg2TM3-TM4d (n=1005),
GFPd (n=825) or GFPdTM3-TM4g2 (n=570). At least 60 %, of clusters at the cell surface have a
size less than 2.5 units (small clusters), at least 25% of them have a size between 2,5 and 7.5
units (medium size clusters) and 5 % or less have a mean radius more than 7.5 units (large
clusters). The n number corresponds to the total number of clusters analyzed for each subunit
construct. Constructs were expressed with the Thy1 promoter.
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per 100 mm dendrite, a significant difference (P < 0.05, Student’s t-test) in the
number of clusters of GFPg2 and GFPd was evident (see Table 3.2). The number of
clusters of GFPg2 was 101±8 per 100 µm of the dendrite; on the other hand the
cluster number of GFPd was 55±8 per 100 µm dendrite. The cluster number of
GFPg2TM3-TM4d was similar to GFPg2, i.e., 97±5 per 100 µm dendrite, suggesting
that the large intracellular TM3-TM4 loops of either the g2 or d subunit do not
influence the differential levels of cluster density of the g2 and d subunit-
containing GABAA receptors on the cell surface. The number of receptor
clusters containing GFPdTM3-TM4g2 subunits was 50±6 clusters per 100 mm
dendritic segment, similar to the cluster number obtained by expressing GFPd.
Chimeric GABAA Rs
Cluster number/100 µm
dendrite
GFPg2 101±8
GFPg2TM3-TM4d  97±5
GFPd  55±8
GFPdTM3-TM4g2  50±6
Table 3.2: Cluster numbers of chimeric GABAA Rs expressed on the cell surface of
transfected hippocampal neurons, DIV 19 shows that the GFPg2  and GFPg2TM3-TM4d subunits
have higher cluster densities in contrast to GFPd and GFPdTM3-TM4g2. At least two dendrites
with 50 to 150 µm in length were analyzed from 5 to 8 neurons expressing each of the
chimeric constructs,When compared with GFPg 2, P value is more than 0.05 for
GFPg2TM3-TM4d and less than 0.05 for GFPd and GFPdTM3-TM4g2.
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3.5 GABAA receptors with the 
GFPg2 subunit are targeted to inhibitory
synapses of primary cultured hippocampal neurons, but receptors with the
GFPd subunit less so.
The sorting, assembly, targeting, and clustering of GABAA receptors are probably
mediated by different domains of the subunits interacting with distinct proteins;
at the time when I began this work, it seemed the most reasonable to hypothesize
that the large cytoplasmic TM3-TM4 domains of these subunits helps specify the
subcellular targeting of the receptor. Given that d subunit-containing GABAA
receptors are located largely extrasynaptically (Nusser et. al., 1998, Wei, et al,
2003), perhaps the TM3-TM4 intracellular domain of this subunit determines this
extracellular location. To examine this possibility, I analyzed quantitatively the
colocalization of receptors containing recombinant g2 and d subunits with
swapped TM3-TM4 domains (Figure 3.1) with the presynaptic markers: glutamic
acid decarboxylase 67 (GAD 67) which selectively marks GABAergic terminals
and synaptophysin which marks both glutamatergic and GABAergic terminals.
Only the images with GAD 67 are shown (Figures 3.5, 3.6, 3.7 and 3.8), but the
quantification of the co-localization of subunit type with presynaptic marker is
given for both GAD 67 and synaptophysin terminals in Figure 3.9. Under our
culture conditions, most terminals in the primary hippocampal cultures are
GABAergic.
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C D
B
Figure 3.5: Cultured hippocampal neurons transfected with GFPg2 and innervated with GABAergic
terminals. Scanning confocal images of hippocampal neurons transfected with GFPg2 followed by
immunostaining with GFP antibody and GAD 67 antibody to localize synaptic and nonsynapting
targeting of chimeric receptors on the membrane. Green color represents the GFP immunoreactivity
of GFPg2 (A) and red color corresponds to GAD terminals innervetad with corresponding neurons
expressing the chimera (B). The overlay (yellow) of green and red is shown in panel C. High
resolution image of dendritic spine in C is shown in D, where there is a high colocalization of GAD
and GFPg2 is observed (see yellow dots shown by white arrows).
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Figure 3.6: Cultured hippocampal neurons transfected with GFPd and innervated with GABAergic
terminals.  Hippocampal neurons DIV19 expressing the GABAA receptor subunit, GFPd  as
visualized by immunostaining with GFP and GAD 67 antibodies to localize synaptic and
nonsynaptic targeting of GABAA receptors on the membrane. A, Green, GFPd; B, red, GAD 67-
postive terminals; C, overlay (yellow). High resolution of the boxed region in C is shown in D,
where a limited colocolazitation of GAD-67 and GABAA receptors with GFPd occurs (yellow dots
marked by white arrows).
A B
C
A
D
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Figure 3.7: Cultured hippocampal neurons transfected with GFPg2TM3-TM4d and innervated with
GABAergic terminals. Hippocampal neurons (DIV19) expressing the GABAA receptor subunit
GFPg2TM3-TM4d as visualized by immunostaining with GFP and GAD 67 antibodies to localize
synaptic and nonsynaptic targeting of GABAA receptors on the membrane. A, green, GFP; B, red,
GAD 67-positive terminals; C, overlay (yellow); D, high resolution of the boxed region in C,
where there is a ‘speculative’ colocalization of GAD 67 and receptors with the GFPg2TM3-TM4d
subunit see yellow dots shown by white arrows).  
B
D
A B
C D
B
C D
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Figure 3.8: Cultured hippocampal neurons transfected with GFPdTM3-TM4g2 and innervated with
GABAergic terminals. Scannining confocal images of hippocampal neurons (DIV19)
immunostained with GFP and GAD 67 antibodies to localize and compare the synaptic and
nonsynapting targeting of GABAA receptor chimeras s on the membrane. A, green, GFP; B, red,
GAD 67-positive terminals; C, overlay (yellow); D, high resolution of the boxed region in  panel
C, where there is a limited colocalization of GAD 67 and GFPdTM3-TM4g2 (see yellow dots
shown by white arrows).
As shown in Figure 3.5, there are many GFPg2 clusters that are not synaptic
besides to synaptic ones (shown by whote arrows). Nevertheless, the average
percentage of co-localized weighted voxels of GFPg2 with GAD 67 immuno-
positive terminals is the highest (more than 55 %, Figure 3. 9A). Similarly, the
average percentage of co-localized weighted voxels of GFPg2 with synaptophysin
immuno-positive terminals is almost 70 % (Figure 3.9B). By contrast, I found
that the GFPd subunit is often located extrasynaptically (Figure 3.6). Receptor
A B
C D
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clusters with the d subunit, as represented by GFP immunoreactivity (green)
(Figure 3.6A), often do not colocalize with GAD 67 immunoreactivity (red)
(Figure 3.6B), when an overlay image is made (Figures 3.6C, D). Indeed, by
contrast with GFPg2, the average percentage of co-localized weighted voxels of
GFPd  with GAD 67 and synaptophsyin immuno-positive terminals was
significantly less (approximately 40% for GAD-67 and 45% for synaptophsyin,
Figures 3.9A and B), according to unpaired Student’s t test with p<0.05.
Nevertheless, there are still quite a few d subunit-containing clusters opposite
presynaptic markers.
3.6 GABAA receptors with the 
GFPg2TM3-TM4d and GFPdTM3-TM4g2
subunits form mostly nonsynaptic clusters
For hippocampal neurons expressing the GFPg2TM3-TM4d  (Figure 3.7A) or
GFPdTM3-TM4g2 subunits (Figure 3.8A), there was often no apparent co-
localization of receptor clusters with GAD 67 immunoreactivity (Figures 3.7B,
3.8B), as assessed by the overlay images (Figures. 3.7C, D, 3.8C, D).
However this phenomenon can not be judged as totally non-synaptic because, as
shown by the white arrows in Figures 3.7D & 3.8D, there are also some receptor
puncta colocalized with GAD 67 immunoreactivity (yellow color).
The percentage of co-localized weighted voxels for both the GFPg2TM3-TM4d
and GFPdTM3-TM4g2 subunits co-localized with GAD-67 and synaptophysin is
similar to that for GFPd, approximately 40% and 45% respectively (Figures 3.9A
and B; p < 0.05 when compared with GFPg2 according to unpaired Student’s t
test).
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Figure 3.9: Average % colocalization frequency of GAD 67 (graph A) and synaptophysin (graph
B) with recombinant g2 and d GABAA receptors expressed in cultured hippocampal neurons DIV
19. Data in these charts represent the percentage colocalized weighted voxels (volume of co
localized voxels over the entire volume of the image above threshold) and are shown as mean ±
SEM of 1-2 dendiritic segments of at least 5 cells (n=5) innervated with presynaptic markers from
triplicate experiments using three independent cultures. Statistical significance was calculated
according to the unpaired Student’s t-test with P < 0.05
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4 DISCUSSION
How GABAA receptor subtypes segregate so precisely to different subcellular
locations is not understood. In this study, I have expressed the recombinant g2
and d GABAA receptor subunits in cultured hippocampal neurons to analyze the
differential cell surface expression and sub-membrane segregation of synaptic
and extrasynaptic GABAA receptors. My data demonstrate that the synaptic
targeting of g2-containing GABAA receptors does not depend on the cytoplasmic
TM3-TM4 domain of the g2 subunit. This result was actually surprising, until
Alldred et al published their work last year (2005) showing that the synaptic
localization of receptors with the g2 subunit requires the TM4 domain rather than
the large TM3-TM4 cytoplasmic loop. The premise of our work, when we
started, was that the loop region would be responsible. On the other hand, I
showed here that the TM3-TM4 cytoplasmic domain of the d subunit is either a
factor for the extra-synaptic clustering of the d containing GABAA receptors (this
would be an active mechanism) or alternatively that this loop region may not
contain any information at all on receptor targeting, and subunits with this
domain may simply lack sufficient “information” to be placed in synapses
(passive exclusion). I cannot currently distinguish between these two
possibilities. Nevertheless, by comparing the d subunit TM3-TM4 loop amino
acid sequences across the whole span of vertebrate evolution, I discovered that
the loop was remarkably conserved. This would suggest that the loop’s tertiary
structure and specific proteins that bind to it are important for some function(s) of
d-containing receptors. A passive exclusion mechanism might have lead to a
degeneration of the loop sequence, as found for example when the GABAA a6
subunit TM3-TM4 loop is compared across the same evolutionary distance (Bahn
et al 1996).
4.1 Synaptic and non-synaptic receptors in general
For efficient and fast (millisecond) synaptic transmission neurotransmitter
receptors are concentrated in synapses. This is universally true, whether when
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considering the Cys loop receptor family (nAChRs clustered at the muscle end
plate opposite motor neuron terminals, GABAARs and GlyRs opposite their
respective terminals in the central nervous system), or the ionotropic glutamate
receptor family (AMPA and NMDA receptors) at the PSD (see Introduction).
Only modulatory type receptors mediating much slower responses (often 7TM G-
protein coupled receptors e.g. metabotropic glutamate or GABAB receptors) or
Cys-loop receptors in the CNS associated with modulatory transmitters that cause
fast responses (nAChRs and maybe 5HT via 5HT3 receptors) are nonsynaptically
located. Nevertheless, it has become appreciated in the last few years that two
types of GABAA receptor transmission co-exist on some types of CNS neurons,
mediating the tonic and phasic components (see Introduction, Sections 1.1.5 and
1.1.6). GABAA receptors with d subunits, most likey a4bd in the forebrain and
a6bd on cerebellar granule cells are exclusively extrasynaptic, whereas a wide
variety of abg2 type receptors occur in both synaptic and extrasynaptic locations.
There is no g2-containing receptor that is exclusively synaptic, although one
might get this impression from some published papers; but the g2 subunit does
confer the ability of the receptor to be placed stably in the synapse or at least, if
considering that lateral diffusion of receptors is happening continuously, that the
g2 subunit increases the receptor dwell time in the synaptic zone. Mice with no g2
subunits have no synaptic clustering of GABAA receptors (Essrich et al, 1998).
Synaptic clustering of GABAA receptors is such an important feature that without
this, life cannot be sustained past the early postnatal period (Gunther et al 1995).
The g1 and g3 subunits are likely to perform a similar role (Seeburg et al, 1990),
but as these subunit genes are only expressed in very specialized cell populations
(Wisden et al 1992), they contribute to only a small fraction of total brain
GABAA receptors.  An additional feature is that the g2 and d subunits confer a
full single channel conductance on the abd or abg2 receptor complex.
The significance of the g2 subunit for GABAA receptor pharmacology was
understood from the beginning (Prtitchett et al 1989): but although the d subunit
sequence was published in the same year as g2 (Shivers et al 1989), d remained a
“dark horse” for a long time. However, Shivers et al 1989 did presciently note
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that the distribution of d  subunit mRNA resembled 3H muscimol
autoradiographic distributions (see Introduction, section 1.1.4.1.1) and that
d receptors may be associated with brain structures that contained glomeruli e.g.
oflfactory bulb, thalamus and cerebellum (which was an accurate and insightful
prediction). Nevertheless, the first reports on d subunit expression in Xenopus
oocytes and HEK cells were unremarkable, and many research groups could not
get stable expression of the subunit in HEK cells. The d knockout mouse study
was also not initially with much impact, being considered at first as something
having a rather subtle phenotype (occasional seizures and changed steroid
sensitivity; Spigelman et al 2003, Mihalek et al 1999, Vicini et al 2002).
However, it is now fair to say that with the discovery and elaboration of studies
of GABAA receptor mediated tonic (extrasynaptic) inhibition (see Introduction,
sections 1.1.6 and 1.1.7), and the likely influence of tonic inhibition in various
pathological states (reviewed by Mody, 2005), the d subunit is currently centre
stage of many GABAA receptor studies. Thus it becomes important to dissect the
mechanism for the targeting of these d subunit-containing receptors, hence the
topic of my thesis.
4.2 Targeting of GABAA receptors to the synapse: what is known so far
about the g2 subunit’s role
Originally, it was anticipated that targeting of GABAA receptors could be
explained by a simple “anchoring protein” concept. In the same Cys loop
receptor family, muscle nicotinic acetylcholine receptors (nAchRs) use rapsyn,
glycine receptors (GlyRs) (very close relatives of GABAA receptors) use
gephyrin. Ionotropic receptors are anchored with complexes of PDZ domain
proteins. In all cases, particularly for the nAchRs and GlyRs receptors, a protein
directly binds the large TM3-TM4 loop of one of the subunits and anchors it
there (Huebsch and Maimone, 2003; Kirsch et al 1993; Kirsh and Betz, 1995).
Indeed this approach, including my own, has dominated the field to search for
TM3-TM4 loop binding proteins (Loebrich et al 2006; Wang et al 1999; Keller et
al 2004). No direct loop-binding proteins have so far turned out to be suitable
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candidates, except possibly radixin (see Loebrich et al 2005). With the discovery
that gephyrin knockout mice had far fewer synaptic GABAA receptors (see
below; Kneussel et al 1999), it seemed natural to suppose that the problem had
been solved. The first optimism was soon dampened when it was found that
gephyrin did not directly bind GABAA receptors, and that only a few subtypes of
receptor were affected, and that the first study had been over interpreted
(Kneussel et al 1999). It further came as a total surprise that the TM4
transmembrane domain of g2 was actually the relevant region of the protein for
synaptic targeting (Alldred et al 2005). Thus the field is full of interesting
challenges. So far, nobody can explain how GABAA receptors are targeted. Most
likely the “anchoring protein” concept still holds, just that the real candidates are
not yet identified.
As a further complexity, the g2 subunit-containing GABAA receptors are targeted
and clustered to different compartments of the neuronal cell membrane
depending on the particular a subunit in the abg2 combination. For example,
GABAA receptors with a2 subunits are enriched on the axonal hillock of
hippocampal pyramidal cells, although they are also present in other doamins
(Nusser et al, 1996); a5bg2 receptors are enriched as extrasynaptic clusters
(Brunig et al 2002), but about 25% of them are postsynaptic. Ectopically
expressing a6bg2 receptors in hippocampal and neocortical pyramidal cells
produces mostly extrasynaptic receptors (Wisden et al., 2002). Thus there is an
extraordinary complex processing of these receptors. It is not just a simple
interaction with the g2 subunit. The a subunits must also play a role, and these
signals must sometimes override the g2 signals depending on which a subunit is
involved. The actin-binding protein radixin anchors extrasynaptic a5 subunits,
and by implication a5-containing receptors to the actin cytosketon via a short
segment in the a5 TM3-TM4 loop, provided that the radixin protein is activated
by phosphorylation (Loebrich et al 2005); radixin is enriched extrasynaptically.
The phenomenon of GABAA receptor targeting is actually quite hard to study
because the distributions, with the exception of the d subunit, do not seem to be
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absolute: g2 receptors are enriched in the synapse, but there are plenty of them
extrasynaptically (Somogyi et al 1996). There is also plenty of gephyrin clusters
extrasynaptically (Danglot et al, 2003). The a2 subunit is enriched in the axon
hillock, but it is also in other areas (Nusser, et al, 1996). The assays of mutations
of protein domains that affect targeting are therefore based on statistical
probabilities: even the receptors with no g2 are found in the synapse. In contrast,
electron microscopy data clearly show that d subunit containing GABAA
receptors are never located on the synapses (Nusser, et. al.,1998; Wei et al,
2003). Therefore I would argue that the synaptic targeting of d subunit and
associated GABAA receptor trafficking might fundamentally differ form g2
containing receptors. In this way the d subunit would be directly targeted always
specially to the extra-synaptic sites from the beginning and clustered selectively.
The intracellular domain of g2 subunit interacts with several proteins that might
facilitate receptor trafficking. For example it interacts with the GABAA receptor
trafficking factor GABARAP (Wang and Olsen, 2000), but since GABARAP is
enriched in Golgi, it appears not to be a major factor for the synaptic clustering.
In fact, mice with no GABARAP protein have normally trafficked and clustered
GABAA receptors, and have no adverse phenotype (O’Sullivan et al 2005). Other
GABARAP-like proteins could compensate, although these are not upregulated
in the knockout; alternatively GABARAP is simply not important for GABAA
receptor function, in spite of the many studies where forced expression of
GABARAP and GABAA receptors influences GABAA receptor function
(reviewed by O’Sullivan et al 2005).
Depolymerizing the neuronal microtubule cytoskeleton causes GABAA receptors
to de-cluster (reviewed by Petrini et al 2004). The microtubule binding protein
gephyrin is a major postsynaptic protein which is highly colocalized with g2-
containing postsynaptic receptors as well as with glycine receptors (Sassoe-
Pognetto, 2000; Schmitt et al, 1987; Prior et al 1992). Although the intracellular
domain of the b subunit of glycine receptors interacts directly with gephyrin to
assemble the aggregation of postsynaptic glycine receptors (Meyer et. al., 1995;
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Kneussel et. al., 1999; Kirsch et. al., 1996), this seems to be not the case for
postsynaptic clustering of g2 containing GABAA receptors (Gunther et. al., 1995;
Essrich et. al., 1998; Schweizer et. al., 2003; reviewed in Loebrich et al 2006).
Indeed, current data (Kirsch, 1999; Kneussel et. al., 1999; Levi, et. al., 2004;
Jacob et. al. 2005) suggest that gephyrin could be used for the maintenance or
refinement rather than construction of inhibitory synapses (reviewed and
elaborated on by Alldred et al 2005).
The palmitoyltransferase GODZ (Keller et. al., 2004) interacts with a cysteine
motif located in the cytoplasmic TM3-TM4 domain of the g2 subunit
(Rathenberg et. al., 2004). Inhibiting this interaction decreases the steady state
cell surface receptor number of GABAA receptors and synaptic clustering which
suggests this domain as a prominent factor for receptor density via its
palmitoylation. Perhaps the TM3-TM4 cytoplasmic domain of g2 subunit is
involved in the modulation of the ratio of density of synaptic versus non-synaptic
g2 containing receptors, rather than the total receptor number for a given state.
This implies that it must be a modulatory element for synaptic plasticity rather
than an essential factor for membrane targeting and synaptic clustering of the
receptors, (although most of the proteins i.e., GABAA receptor acting proteins,
GABAA receptor-associated adaptors, kinases, phosphateses, and extracellular
signals (reviewed by Luscher and Keller, 2004) that have been identified as the
modulators of the trafficking and cell surface expression of GABAA receptors
interact mainly with b subunits).
4. Discussion
62
4.3 The cytoplasmic domain (TM3-TM4 loop) of the g2 subunit, when placed
into the context of a d subunit backbone, is not directly involved in synaptic
clustering or targeting of GABAARs and does not influence cluster number
I have shown that the synaptic clustering of GABAA receptors does not depend
on the cytoplasmic domain of the g2 subunit. On the other hand, another group
using a similar experimental paradigm to ours (except they used C-termally
EGFP-tagged subunits rather than N-terminal tags) has also recently addressed
the importance of the TM3-TM4 domain as a major factor for synaptic GABAA
receptor targeting; they found a significant reduction in the synaptic targeting of
receptors containing GFPg2TM3-TM4d chimeric subunits compared with receptors
containing GFPg2 (Christie, et. al., 2005). Our data agree with the reduced
clustering at synaptic sites for the GFPg2TM3-TM4d subunit, but since we have
used both GFPgTM3-TM4d and GFPdTM3-TM4g2 chimeric subunits as test
constructs in our experiments (Christe et al could not get d-based chimeras to
express), we demonstrate that the ‘deviation’ of the GFPg2TM3-TM4d  construct
from the synaptic targeting profile of the GFPg2 control construct was not because
of lack of the TM3-TM4 domain of the g2 subunit but due to the existence of the
corresponding domain of d subunit. I showed using a GFPdTM3-TM4g2 subunit
that the TM3-TM4 domain of  g2 was not sufficient to provide a preferential
synaptic clustering on the rest of the d subunit backbone (d subunit N-terminal
area, four transmembrane domains, i.e., TM1, TM2, TM3, TM4 and C terminus,
but not the cytoplasmic loop). Therefore the cytoplasmic domain of g2 subunit, at
least by itself, is not a major factor for synaptic clustering of GABAA receptors.
In agreement with our data, Alldred et al., (2005) have recently reported that the
fourth transmembrane domain (TM4) of this subunit is actually the critical
domain for synaptic targeting of g2 containing GABAA receptors. Similarly, the
TM4 domain of a  and b subunits of nAChRs have been proposed to interact
directly with the phospholipid bilayer of the cell membrane, facilitating the
postsynaptic clustering of these receptors, presumably in collaboration with
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rapsyn binding the large TM3-TM4 loop (Bruses et. al, 2001; Hering et. al.,
2003; Pediconi et. al., 2004, Alldred et. al., 2005).
As a further finding, I discovered that the TM3-TM4 g2 cytoplasmic domain is
not critical for receptor cluster density: if it were, the chimeric g2 subunit
possessing the large TM3-TM4 cytoplasmic domain of the d subunit (GFPg2TM3-
TM4d) would have given GABAA receptors with a corresponding decrease in the
receptor density; however my data show that this was not the case, rather the
receptor density was almost unchanged. Similarly, d  subunits with the
cytoplasmic domain of g2 subunit did not influence receptor density as this had
almost the same value for the receptor density as just the d.
4.4 The large TM3-TM4 cytoplasmic domain of the d subunit: a putative
domain for the selective extrasynaptic targeting of d subunit-containing
GABAA receptors
I found a statistically significant reduction in the synaptic clustering of GABAA
receptors with the GFPg2TM3-TM4d subunit compared to receptors with GFPg2. In
other words, the GFPg2TM3-TM4d subunit chimera behaves like GFPd  as regards
preferential nonsynaptic localization on the cell surface of hippocampal neurons.
How does the cytoplasmic domain (TM3-TM4 loop) of d subunit specify the
nonsynaptic targeting of associated receptors? Does it lack the necessary motifs
for synaptic clustering, and is therefore restricted from the synapses and located
extrasynaptically by default (passive mechanism)? Alternatively, does the d
subunit have some specific motifs that anchor receptors containing it selectively
to the nonsynaptic zones (active mechanism)? Indeed, one of the test constructs
(GFPg2TM3-TM4d) that we have used in our culture system to study the membrane
targeting pattern may hint at an active mechanism for the nonsynaptic clustering
of d-containing GABAA receptors. This chimera consists of the large TM3-TM4
intracellular loop from the d subunit but the rest of the subunit is composed of the
original g2 peptides, including the g2 TM4 domain critical for the synaptic
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clustering. Therefore this GFPg2TM3-TM4d chimera represents the model for the
competition of two different domains (g2TM4 and dTM3-TM4 loop) with
opposing effects on the synaptic versus nonsynaptic targeting.  When expressed
exogeneously in the cultured hippocampal neurons, this chimeric subunit most
probably co-assembles with endogeneous a and b subunits to give a mixture of
receptors located synaptically (g2 TM4 influence) and extrasynaptically (d loop
influence), with the majority of receptors extrasynaptic. This possibly
competitive action between domains might explain why many receptors (40%)
are still in the synapse. On the other hand, as the GFPdTM3-TM4g2 behaves
similarly to GFPg2TM3-TM4d, giving the same extrasynaptic versus synaptic
distribution, and would rather undermine the previous argument. To more
rigorously test this, I would have to make subunit chimeras with say the d subunit
up until TM3 followed by the entire g2 subunit including TM4 sequences, and
vice versa.
4.5 GFPd subunit-containing GABAA receptors form clusters on the cell
surface of hippocampal neurons
I have shown that similar to g2 containing GABAA receptors, d subunit-
containing GABAA receptor chimeras are not- diffusely distributed, as perhaps
might have been expected, but instead, when expressed ectopically in
hippocampal pyramidal cells, form clusters. This result with d subunits contrasts
with the results obtained by Christie et al 2005, who found that the recombinant d
subunit, tagged with GFP at its C-terminus, when expressed ectopically in
hippocampal pyramidal neurons was diffusely distributed extrasynsptically. They
used C-terminally tagged d with EGFP; this might give a different result.
Why do extrasynaptic d-containing GABAA receptors form clusters? For
extrasynaptic a5bg2 GABAARs, which are also highly clustered, the clustering
does not seem to be important for the associated tonic inhibition (discussed in
Loebrich et. al. 2006). The d receptors in clusters may exist as “GABA-sensitive”
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rafts in the extrasynaptic membrane. Interestingly, in the case of d-containing
GABAA receptors in hippocampal cultures, de-clustering by inhibiting the
polymerization of microtubules leads to a decrease in the associated tonic
inhibition, possibly indicating that the degree of clustering regulates tonic
inhibition (Petrini et. al., 2004). However, the findings in this paper are based on
an apparent strong reactivity with a d subunit antibody that stains putative
pyramidal cells; as d is not normally expressed in hippocampal pyramidal cells in
vivo, or at least only at a low level, this paper should be interpreted with caution.
Do clusters of d-containing GABAA receptors occur on native neurons? Yes. Sun
et al 2004 found d  subunit clusters on dentate granule cell bodies, in rat
hippocampal slices, and also some diffuse membrane staining; the d  subunit
clusters rarely occurred opposite GAD-positive terminals, frequency of about 1%
(Sun et al 2004). However, using the same antibody, the same group also found
non-clustered d immunoreactivity on cultured hippocampal neurons (Mangan et
al 2005), but one wonders what kind of staining they were really looking at, and
if this was really specific, a common problem with antibodies.
4.6 Caveats to the hippocampal neuron transfection experiments
4.6.1 Limitations on forced ectopic expression of subunits
The d subunit is not normally expressed in either developing or adult
hippocampal pyramidal cells in vivo, or if it is, the levels are very low  (Wisden
et al 1992; Sperk et al 1997). In my study, forced expression of the d subunit in
these cultured pyramidal cells is thus ectopic. Further, the CMV and Thy1-2
promoters are quite powerful; overexpressing a subunit could flood the natural
subunit assembly mechanisms of the cells and produce artifactual results. Ideally,
one would need to repeat these experiments using an in vivo setting, expressing
the subunit chimeras at physiological amounts in cell types which normally
express the d subunit (e.g. dentate granule cells, cerebellar granule cells, certain
thalamic relay cells). The danger of interpreting in vitro experiments by forced
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subunit expression is highlighted by the a6 knockout mouse (Jones et al 1997).
With no a6 protein, the d protein disappears from granule cells (Jones et al
1997). There is plenty of a1 subunit left in the granule cells, but it does not save
the d subunit from degredation, even though in HEK cells a1 assembles well
with the d. Cell-type mechanisms for subunit assembly must be taken into
account.
4.6.2 Limitations of light microscopy
From the images I obtained with the confocal microscope, I concluded that many
d-related subunits were in the synapse, as judged by apparent co-localization with
presynaptic markers. However, the subunits could be perisynaptic in an annulus
i.e. they could be surrounding the synapse rather than actually in the synapse. The
light miscroscope does not give accurate resolution. This would change the
interpretation of my experiments. This annular arrangement exists for native d
subunits on dentate granule cells as seen by electron microscopy (Wei et al,
2003).
4.7 Evolutionary conserved regions in the TM3-TM4 loop of the d and g2
subunits of GABAARs
I was interested to use a bioinformatics approach to examine if there may be
some functional motifs in the cytoplasmic domain (TM3-TM4 loop) of the
d subunit that might confer some protein-protein interactions. Amino acid
sequence comparisons of gene orthologues across large stretches of evolutionary
time (e.g. 550 million years separating fish and mammals) might indicate
particularly important sequences, as they would have survived purifying natural
selection, assuming the mechanism of receptor targeting also to be conserved. By
aligning multiple sequences of the predicted cytoplasmic TM3-TM4 domain of
the d subunit across vertebrate species, I identified fully or partially evolutionary
conserved aminoacid residues (Figure 4.1). Moreover, some of these residues
(green and yellow boxes in the Figure 10) seem to be frequently occurring motifs
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in the proteins according to ENSEMBL database (see Methods section 2.5). I
identified a putative site (S378, X379, R380) for protein kinase C (PKC), which
is evolutionary conserved in the d subunit of vertebrates including fish species
and chicken (Figure 4.1). Therefore this motif might have an important influence
on receptor function, but it is difficult to propose any functional role for this
motif without experimental evidence.
Figure 4.1: Aminoacid alignment of cytoplasmic domain (TM3-TM4 loop) of d subunit across
vertebrates. 2 putative motifs (SXR) for phosphokinase C (PKC) site is shown by green boxes.
One of these, the residues S 378, X379, R380 (according to mouse) is evolutionary conserved.
The VLFSLS at the proximity of S378 is also 100% conserved. There are also 3 myristoylation
sites as shown by big or small yellow boxes. Two of these sites are partially conserved (big
yellow boxes).
- - - - - - - - - - - - - - - - - - - - - - - A M N D I G D Y V G S N L E I S W L P N L D G L M E G Majority
10 20 30 40 50
M D V L G W L L L P L L L L C T Q P H H G A R A M N D I G D Y V G S N L E I S W L P N L D G L M E G 1 mouse
M D A P A R L L A P L L L L C A Q Q L R G T R A M N D I G D Y V G S N L E I S W L P N L D G L I A G 1 human
M D V L G W L L L P L L L L C T Q P H H G A R A M N D I G D Y V G S N L E I S W L P N L D G L M E G 1 rat
- - - - - - - - - - - - - - - - - - - - - - - A M N D I G D Y V G S N L E I S W L P N L D G L I A G 1 chimp partial
- - - - - - - - - - - - - - - - - - - - - - - A M N D I G D Y V G S N L E I S W L P N L D G L I E G 1 cow
- - - - - - - - - - - - - - - - - - - - - - - - M N D I G D Y V G S N L E I S W L P N L D G L M D G 1 dog
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 1 pig partial
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 1 zebrafish partial
- - - - - - - - - - - - L L C F P F V S S R A M L S D I G D Y V G T D V E I S W L P N L D D L M K G 1 green puffer
I N - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 1 chicken partial
Y A R N F R P G I G G P P V N V A L A L E V A S I D H I S E A N M E Y T M T V F L H Q S W R D S R L Majority
60 70 80 90 100
Y A R N F R P G I G G A P V N V A L A L E V A S I D H I S E A N M E Y T M T V F L H Q S W R D S R L 51 mouse
Y A R N F R P G I G G P P V N V A L A L E V A S I D H I S E A N M E Y T M T V F L H Q S W R D S R L 51 human
Y A R N F R P G I G G P P V N V A L A L E V A S I D H I S E A N M E Y T M T V F L H Q S W R D S R L 51 rat
Y A R N F R P G I G G P P V N V A L A L E V A S I D H I S E A N M E Y T M T V F L H Q S W R D S R L 28 chimp partial
Y A R N F R P G I G G E S - - - - - - - G C R T R E D P G S G H D E Y T M T V F L H Q S W R D S R L 28 cow
Y A R N F R P G I G G P P V N V A L A I E V A S I D H I S E V N M E Y T M T V F L H Q S W R D S R L 27 dog
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 1 pig partial
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 1 zebrafish partial
Y A R N F R P G I G G P P V N V A M A I E V A S I D H I S E A N M E Y T M T V F L R Q S W H D D R L 39 green puffer
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 3 chicken partial
S Y N H T N E T L G L D S R F V D K L W L P D T F I V N A K S A W F H D V T V E N K L I R L Q P D G Majority
110 120 130 140 150
S Y N H T N E T L G L D S R F V D K L W L P D T F I V N A K S A W F H D V T V E N K L I R L Q P D G 101 mouse
S Y N H T N E T L G L D S R F V D K L W L P D T F I V N A K S A W F H D V T V E N K L I R L Q P D G 101 human
S Y N H T N E T L G L D S R F V D K L W L P D T F I V N A K S A W F H D V T V E N K L I R L Q P D G 101 rat
S Y N H T N E T L G L D S R F V D K L W L P D T F I V N A K S A W F H D V T V E N K L I R L Q P D G 78 chimp partial
S Y N H T N E T L G L D S R F V D K L W L P D T F I V N A K S A W F H D V T V E N K L I R L Q P D G 71 cow
A Y N H T N E T L G L D S R F V D K L W L P D T F I V N A K S A W F H D V T V E N K L I R L Q P D G 77 dog
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 1 pig partial
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - S M V K - - - - - 1 zebrafish partial
S Y N H T N K T L G L D S R F V D K L W L P D T F I V N A K S A W F H D V T V E N K L I R L Q P N G 89 green puffer
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 3 chicken partial
V I L Y S I R I T S T V A C D M D L A K Y P M D E Q E C M L D L E S Y - - - - - - - - - - - - - - - Majority
160 170 180 190 200
V I L Y S I R I T S T V A C D M D L A K Y P L D E Q E C M L D L E S Y - - - - - - - - - - - - - - - 151 mouse
V I L Y S I R I T S T V A C D M D L A K Y P M D E Q E C M L D L E S Y - - - - - - - - - - - - - - - 151 human
V I L Y S I R I T S T V A C D M D L A K Y P M D E Q E C M L D L E S Y - - - - - - - - - - - - - - - 151 rat
V I L Y S I R I T S T V A C D M D L A K Y P M D E Q E C M L D L E S Y - - - - - - - - - - - - - - - 128 chimp partial
V I L Y S I R I T S T V A C D M D L A K Y P M D E Q E C M L H L E S - - - - - - - - - - - - - - - - 121 cow
V I L Y S I R I T S T V A C D M D L A K Y P M D E Q E C M L H L E S Y - - - - - - - - - - - - - - - 127 dog
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 1 pig partial
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 5 zebrafish partial
V I L Y S S R I T S T V A C D M D L T K Y P M D E Q E C R L D L E S C K S T S S N T F A L L A P F I 139 green puffer
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 3 chicken partial
- - - - - - - - - - - - - - - - - - G Y S S E D I V Y Y W S E - Q E - I H G L D K L Q L A Q F T I T Majority
210 220 230 240 250
- - - - - - - - - - - - - - - - - - G Y S S E D I V Y Y W S E N Q E Q I H G L D R L Q L A Q F T I T 186 mouse
- - - - - - - - - - - - - - - - - - G Y S S E D I V Y Y W S E S Q E H I H G L D K L Q L A Q F T I T 186 human
- - - - - - - - - - - - - - - - - - G Y S S E D I V Y Y W S E N Q E Q I H G L D R L Q L A Q F T I T 186 rat
- - - - - - - - - - - - - - - - - - G Y S S E D I V Y Y W S E S Q E H I H G L D K L Q L A Q F T I T 163 chimp partial
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 155 cow
- - - - - - - - - - - - - - - - - - G Y S S E D I V Y Y W S E N Q E Q I H G L N K L Q L A Q F T I T 162 dog
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 1 pig partial
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 5 zebrafish partial
F I P S N H T A L E K H H C V F V D G Y S S E D I V Y H W S E S Q Q H V H G L D K L E L S Q F T I T 189 green puffer
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 3 chicken partial
S Y R F T T E L M N F K S A G Q F P R L S L H F H L R R N R G V Y I I Q S Y M P S V L L V A M S W V Majority
260 270 280 290 300
S Y R F T T E L M N F K S A G Q F P R L S L H F Q L R R N R G V Y I I Q S Y M P S V L L V A M S W V 218 mouse
S Y R F T T E L M N F K S A G Q F P R L S L H F H L R R N R G V Y I I Q S Y M P S V L L V A M S W V 218 human
S Y R F T T E L M N F K S A G Q F P R L S L H F Q L R R N R G V Y I I Q S Y M P S V L L V A M S W V 218 rat
S Y R F T T E L M N F K S A G Q F P R L S L H F H L R R N R G V Y I I Q S Y M P S V L L V A M S W V 195 chimp partial
- - - - - - - - - - - - - S G Q F P R L S L H F H L R R N R G V Y I I Q S Y M P S V L L V A M S W V 155 cow
S Y H F A T E L M N F K S A G Q F P R L S L H F H L R R N R G V Y I I Q S Y M P S I L L V A M S W V 194 dog
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - Q S Y M P S I L L V A M S W V 1 pig partial
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 5 zebrafish partial
D Y R F D T E M M N F K S A G R F P R L S L C F Q L R R N R G V Y I I Q S Y M P S I L L V A M S W V 239 green puffer
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 3 chicken partial
S F W I S Q A A V P A R V S L G I T T V L T M T T L M V S A R S S L P R A S A I K A L D V Y F W I C Majority
310 320 330 340 350
S F W I S Q A A V P A R V S L G I T T V L T M T T L M V S A R S S L P R A S A I K A L D V Y F W I C 268 mouse
S F W I S Q A A V P A R V S L G I T T V L T M T T L M V S A R S S L P R A S A I K A L D V Y F W I C 268 human
S F W I S Q A A V P A R V S L G I T T V L T M T T L M V S A R S S L P R A S A I K A L D V Y F W I C 268 rat
S F W I S Q A A V P A R V S L G I T T V L T M T T L M V S A R S S L P R A S A I K A L D V Y F W I C 245 chimp partial
S F W I S Q A A V P A R V S L G I T T V L T M T T L M V S A R S S L P R A S A I K A L D V Y F W I C 192 cow
S F W I S Q A A V P A R V S L G I T T V L T M T T L M V S A R S S L P R A S A I K A L D V Y F W I C 244 dog
S F W I S Q A A V P A R V S L G I T T V L T M T T L M V S A R S S L P R A S A I K A L D V Y F W I C 16 pig partial
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 5 zebrafish partial
S F W I S Q S A V P A R V T L G I T T V L T M T T L M V S A R S S L P R A S A I K A L D V Y F W I C 289 green puffer
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 3 chicken partial
Y V F V F A A L V E Y A F A H F N A D Y R K K Q K A K - - - - V K V S E P R A E M D V K N A I V L F Majority
360 370 380 390 400
Y V F V F A A L V E Y A F A H F N A D Y R K K R K A K - - - - V K V T K P R A E M D V R N A I V L F 318 mouse
Y V F V F A A L V E Y A F A H F N A D Y R K K Q K A K - - - - V K V S R P R A E M D V R N A I V L F 318 human
Y V F V F A A L V E Y A F A H F N A D Y R K K R K A K - - - - V K V T K P R A E M D V R N A I V L F 318 rat
Y V F V F A A L V E Y A F A H F N A D Y R K K Q K A K - - - - V K V S R P R A E M D V R N A I V L F 295 chimp partial
Y V F V F A A L V E Y A F A H F N A D Y R K K Q K A K A K A K V K V K E Q R A E M D V K N A I V L F 242 cow
Y V F V F A A L V E Y A F A H F N A D Y R K K Q K A K A K A K V K V T E Q R A E M D V K N A I V L F 294 dog
Y V F V F A A L V E Y A F A H F N A D Y R K K Q K A K A K V K - - - - E Q R A E M D V R S A I V L F 66 pig partial
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - N G K Q A M V L F 5 zebrafish partial
Y V F V F A A L I E Y A F A H Y N A D Y R L K E K A K V K A S - K L S S E S I V K N G K Q A M V L F 339 green puffer
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - V K N A I V L F 3 chicken partial
S L S A A G V T Q E L A I S R R Q G R V P G N L M G S Y R S V E V - E T G E T K K E G G A R A G G Q Majority
410 420 430 440 450
S L S A A G V S Q E L A I S R R Q G R V P G N L M G S Y R S V E V - E A - - - K K E G G S R P G G P 364 mouse
S L S A A G V T Q E L A I S R R Q R R V P G N L M G S Y R S V G V - E T G E T K K E G A A R S G G Q 364 human
S L S A A G V S Q E L A I S R R Q G R V P G N L M G S Y R S V E V - E A - - - K K E G G S R P G G P 364 rat
S L S A A G V T Q E L A I S R R Q R R V P G N L M G S Y R S V G V - E T G E T K K E G A A R S G G Q 341 chimp partial
S L S A A G V T Q E L A V S R R P C R L P G N L M G S Y R S V E V - E T G E T K K Q - - - - - G S Q 292 cow
S L S A A G V T Q E L A V S R R Q C R R P G N L M G S Y R C V E V - E T G E A K K Q R G A R A G G Q 344 dog
S L S A A G V T Q E L A V S R R Q C R V P G N L M G S Y R S M E V - E T G E T K K Q - - - - G G G R 112 pig partial
S L S V A G M N Q G L L I S N R Q S R S H R A S D A A A A A A D P H E E T E T R S A T S R R A Q K E 14 zebrafish partial
S L S V T G M N Q S V M I S N R Q G R A Q R S S S E I P G E A A S - E E A E P R R R R S K Q T E E P 388 green puffer
S L S I A G V S Q E L A I S N R Q H R I P R S L P G S Y G T I E I - E T G E T K Q Q Q E M K L D K K 11 chicken partial
G G L R A - - - - - L L K P I D A D T I D I Y A R A V F P A A F A A V N V I Y W A A Y T M - - - - - Majority
460 470 480 490 500
G G I R S - - - - - R L K P I D A D T I D I Y A R A V F P A A F A A V N I I Y W A A Y T M           410 mouse
G G I R A - - - - - R L R P I D A D T I D I Y A R A V F P A A F A A V N V I Y W A A Y - - A - - - - 413 human
G G I R S - - - - - R L K P I D A D T I D I Y A R A V F P A A F A A V N I I Y W A A Y T M           410 rat
G G I R A - - - - - R L R P I D A D T I D I Y A R A V F P A A F A A V N V I Y W A A Y A M - . A P D 390 chimp partial
G G L R G - - - - - L L K P I D A D T I D I Y A R A V F P A A F A A V N V I Y W A A Y T M           336 cow
G G L R T - - - - - L F K P I D A D T I D I Y A R V V F P A A F V A V N V L Y W A A Y A M           393 dog
G G L R A - - - - - L F K P I D A D T                                                               157 pig partial
S S E E K K C C K C - - K P I D A D T I D I Y A R A V F P F T F A V V N V I Y W V A Y T M .         64 zebrafish partial
K E E K K C C S K C V C K P I D A D T I D I Y A R A V F P F T F A V V N V I Y W V A Y T M           437 green puffer
S G L K S - - - - - L F K P I D A D T I D I Y A R A V F P A A F A A V N V I Y W V A Y T M           60 chicken partial
- - - - - - - - - - - - - - - - - Majority
510
                                                                                                    449 mouse
- - - - - - - - - - - - - - - M                                                                     452 human
                                                                                                    449 rat
S G H P R L S W R P A A A A Q K L                                                                   434 chimp partial
                                                                                         375 cow
                                                                                                    432 dog
                                                                                                    170 pig partial
                                                                                                    107 zebrafish partial
                                                                                                    481 green puffer
                                                                                                    99 chicken partial
Decoration 'Decoration #1': Shade (with solid black) residues that match the Consensus exactly.
TM 3 Cytoplasmic domain (TM3-TM4 loop)
TM4
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However, it is generally known that GABAA receptor phosphorylation is a major
mechanism for the modulation of receptor activity i.e., the channel kinetics or
receptor internalization, via the residues within the intracellular domains of
mainly b and g2 receptor subunits by a range of serine theronine and tyrosine
kinases in a subunit and neuron-specific manner (reviewed by Kittler and Moss,
2003).
Interestingly, multiple aminoacid alignment of cytoplasmic domain (TM3-TM4
loop) of g2 subunit (Figure 4.2) is much more conserved when compared with
that of d subunit (Figure 4.1). The homology between cytoplasmic domain of g2
subunit from human and chicken lines which are thought to have diverged about
300 million years ago could be aligned with 100% similarity. In the fugu fish,
which diverged from the human line more than 400 million years ago, partially
sequenced regions could be aligned with almost 90 % similarity (Figure 4.2).
Although the cytoplasmic domain of g2 subunit does not appear to be
determinant for synaptic clustering of GABAA receptors (see section 4.3), the
appareantly conserved aminoacids shown in the Figure 4.2 addresses that the this
domain (TM3-TM4 loop) have some very important roles in the receptor
function. In deed current data in the literature suggest that extracellular signals
and activity-dependent modulation of GABAergic synapses is mediated by
phosphorylation and Ca2+ dependent signaling cascades, especially on the b
subunit variants as well as g2 subunit in the TM3-TM4 loop region (rewieved in
Luscher and Keller, 2004). Therefore the strong conservation in the TM3-TM4
loop region of g2 subunit among the whole span of vertebrate evolution is inline
with the view supporting its potential for synaptic plasticity. However, further
investigation needs to be done to refine this point of view, because the effect of
any interacting partners on the trafficking, stability and function of GABAA
receptors is not known.
With this study I have identified the TM3-TM4 loop of the d subunit as a key
element for the extrasynaptic targeting of corresponding GABAA receptors; these
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receptors appear to have a fundamentally different targeting mechanism than
synaptic g2-containing GABAA receptors.
Determination of functional motifs and interacting partners with mutagenesis
experiments and GST pull down assays will be useful for furthering our, so far
very limited, knowledge of mechanisms involved in regulating protein sorting in
neurons, and eventually feed into the larger picture of how neuronal diversity is
generated.   
M - - - N - - - - G S - - - - - P - F S - K M T L W I L L L L S L Y P G F T S Q K S D D D Y E D Y A Majority
10 20 30 40 50
M - - - - - - - - - - - - - - - - - - - - - - T L W I L L L L S L Y P G F T S Q K S D D D Y E D Y A 1 gabrg2 mouse
M S S P N I W S T G S S V Y S T P V F S Q K M T V W I L L L L S L Y P G F T S Q K S D D D Y E D Y A 1 gabrg2 human
M S S P N T W S T G S T V Y S - P V F S Q K M T L W I L L L L S L Y P G F T S Q K S D D D Y E D Y A 1 gabrg2 rat
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 1 gabrg2 chimp 
M S S P N I W S T G S S V Y S T P V F S Q K M T L W I L L L L S L Y P G L T R Q K S D D D Y E D Y A 1 gabrg2 bovin
M T P S N P T R L G S T A L L N P A F S L K M M V W A L V F L S L I Q C - S T Q K G D D D Y E D Y T 1 gabrg2 chick
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - S F Q S D D D D E - - - - - V 1 gabrg2 pufferfish
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - S F Q S D D D D E - - - - - V 1 gabrg2 tetraodon
S N K T W V L T P K V P E G D V T V I L N N L L E G Y D N K L R P D I G V K P T L I H T D M Y V N S Majority
60 70 80 90 100
S N K T W V L T P K V P E G D V T V I L N N L L E G Y D N K L R P D I G V K P T L I H T D M Y V N S 29 gabrg2 mouse
S N K T W V L T P K V P E G D V T V I L N N L L E G Y D N K L R P D I G V K P T L I H T D M Y V N S 51 gabrg2 human
S N K T W V L T P K V P E G D V T V I L N N L L E G Y D N K L R P D I G V K P T L I H T D M Y V N S 50 gabrg2 rat
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 1 gabrg2 chimp 
S N K T W V L T P K V P E G D V T V I L N N L L E G Y D N K L R P D I G V K P T L I H T D M Y V N S 51 gabrg2 bovin
S N K T W V L T P K V H E S D V T L I L N G L L E G Y D N K L R P D I G V K P T V I H T D M Y V N S 50 gabrg2 chick
S N K T W V L T P K V Y E S D V T H I L N S L L D G Y D N K L R P D I G - - - - - - - - - - - - - - 11 gabrg2 pufferfish
S N K T W V L T P K V Y E S D V T H I L N S L L D G Y D N K L R P D I G - - - - - - - - - - - - - - 11 gabrg2 tetraodon
I G P V N A I N M E Y T I D I F F A Q T W Y D R R L K F N S T I K V L R L N S N M V G K I W I P D T Majority
110 120 130 140 150
I G P V N A I N M E Y T I D I F F A Q T W Y D R R L K F N S T I K V L R L N S N M V G K I W I P D T 79 gabrg2 mouse
I G P V N A I N M E Y T I D I F F A Q T W Y D R R L K F N S T I K V L R L N S N M V G K I W I P D T 101 gabrg2 human
I G P V N A I N M E Y T I D I F F A Q T W Y D R R L K F N S T I K V L R L N S N M V G K I W I P D T 100 gabrg2 rat
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 1 gabrg2 chimp 
I G P V N A I N M E Y T I D I F F G Q T W Y D R R L K F N S T I K V L R L N S N M V G K I W I P D T 101 gabrg2 bovin
I G P V N A I N M E Y T I D I F F A Q T W Y D R R L K F N S T I K V L R L N S N M V G K I W I P D T 100 gabrg2 chick
- - - - - - - - - E Y T I D I F F A Q T W Y D R R L K F N S T M K V L R L N S N M V G K I W I P D T 47 gabrg2 pufferfish
- - - - - - - - - E Y T I D I F F A Q T W F D R R L K F N S T M K V L R L N S N M V G K I W I P D T 47 gabrg2 tetraodon
F F R N S K K A D A H W I T T P N R M L R I W N D G R V L Y T L R L T I D A E C Q L Q L H N F P M D Majority
160 170 180 190 200
F F R N S K K A D A H W I T T P N R M L R I W N D G R V L Y T L R L T I D A E C Q L Q L H N F P M D 129 gabrg2 mouse
F F R N S K K A D A H W I T T P N R M L R I W N D G R V L Y T L R L T I D A E C Q L Q L H N F P M D 151 gabrg2 human
F F R N S K K A D A H W I T T P N R M L R I W N D G R V L Y T L R L T I D A E C Q L Q L H N F P M D 150 gabrg2 rat
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 1 gabrg2 chimp 
F F R N S K K A D A H W I T T P N R M L R I W N D G R V L Y T L R L T I D A E C Q L Q L H N F P M D 151 gabrg2 bovin
F F R N S K K A D A H W I T T P N R M L R I W N D G R V L Y T L R L T I D A E C Q L Q L H N F P M D 150 gabrg2 chick
F F R N S K K A D A H W I T T P N R M L R I W N D G R I L Y T L - - - - - - - - - - - - - - - - - - 88 gabrg2 pufferfish
F F R N S K K A D A H W I T T P N R M L R I W N D G R I L Y T L - - - - - - - - - - - - - - - - - - 88 gabrg2 tetraodon
E H S C P L E F S S Y G Y P R E E I V Y Q W K R S S V E V G D T R S W R L Y Q F S F V G L R N T T E Majority
210 220 230 240 250
E H S C P L E F S S Y G Y P R E E I V Y Q W K R S S V E V G D T R S W R L Y Q F S F V G L R N T T E 179 gabrg2 mouse
E H S C P L E F S S Y G Y P R E E I V Y Q W K R S S V E V G D T R S W R L Y Q F S F V G L R N T T E 201 gabrg2 human
E H S C P L E F S S Y G Y P R E E I V Y Q W K R S S V E V G D T R S W R L Y Q F S F V G L R N T T E 200 gabrg2 rat
- - - - - - - - - - - G Y P R E E I V Y Q W K R S S V E V G D T R S W R L Y Q F S F V G L R N T T E 1 gabrg2 chimp 
E H S C P L E F S S Y G Y P R E E I V Y Q W K R S S V E V S D T R S W R L Y Q F S F V G L R N T T E 201 gabrg2 bovin
A H S C P L E F S S Y G Y P R E E I I Y Q W K R S S V E V G D T R S W R L Y Q F S F T G L R N T T E 200 gabrg2 chick
- - - - - - - - - - - G Y P R E E I V Y K W K R S S V E V G D I R S W R L Y Q F S F V G L R N T S E 120 gabrg2 pufferfish
- - - - - - - - - - - G Y P R E E I V Y K W K R S S V E V G D V R S W R L Y Q F S F V G L R N T S E 120 gabrg2 tetraodon
V V K T T S G D Y V V M S V Y F D L S R R M G Y F T I Q T Y I P C T L I V V L S W V S F W I N K D A Majority
260 270 280 290 300
V V K T T S G D Y V V M S V Y F D L S R R M G Y F T I Q T Y I P C T L I V V L S W V S F W I N K D A 229 gabrg2 mouse
V V K T T S G D Y V V M S V Y F D L S R R M G Y F T I Q T Y I P C T L I V V L S W V S F W I N K D A 251 gabrg2 human
V V K T T S G D Y V V M S V Y F D L S R R M G Y F T I Q T Y I P C T L I V V L S W V S F W I N K D A 250 gabrg2 rat
V V K T T S - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 40 gabrg2 chimp 
V V K T T S G D Y V V M T V Y F D L S R R M G Y F T I Q T Y I P C T L I V V L S W V S F W I N K D A 251 gabrg2 bovin
V V K T T S G D Y V V M S V Y F N L S R R M G Y F T I Q T Y I P C T L I V V L S W V S F W I N K D A 250 gabrg2 chick
V V R T - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 159 gabrg2 pufferfish
V V R T - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 159 gabrg2 tetraodon
V P A R T S L G I T T V L T M T T L S T I A R K S L P K V S Y V T A M D L F V S V C F I F V F S A L Majority
310 320 330 340 350
V P A R T S L G I T T V L T M T T L S T I A R K S L P K V S Y V T A M D L F V S V C F I F V F S A L 279 gabrg2 mouse
V P A R T S L G I T T V L T M T T L S T I A R K S L P K V S Y V T A M D L F V S V C F I F V F S A L 301 gabrg2 human
V P A R T S L G I T T V L T M T T L S T I A R K S L P K V S Y V T A M D L F V S V C F I F V F S A L 300 gabrg2 rat
- - - - - - - - I T T V L T M T T L S T I A R K S L P K V S Y V T A M D L F V S V C F I F V F S A L 46 gabrg2 chimp 
V P A R T S L G I T T V L T M T T L S T I A R K S L P K V S Y V T A M D L F V S V C F I F V F S A L 301 gabrg2 bovin
V P A R T S L G I T T V L T M T T L S T I A R K S L P K V S Y V T A M D L F V S V C F I F V F S A L 300 gabrg2 chick
- - - - - - V S I T T V L T M T T L S T I A R K S L P K V S Y V T A M D L F V S V C F I F V F A A L 163 gabrg2 pufferfish
- - - - - - V S I T T V L T M T T L S T I A R K S L P K V S Y V T A M D L F V S V C F I F V F A A L 163 gabrg2 tetraodon
V E Y G T L H Y F V S N R K P S K D K D K K K K N P L L R M F S F K A P T I D I R P R S A T I Q M N Majority
360 370 380 390 400
V E Y G T L H Y F V S N R K P S K D K D K K K K N P - - - - - - - - A P T I D I R P R S A T I Q M N 329 gabrg2 mouse
V E Y G T L H Y F V S N R K P S K D K D K K K K N P L L R M F S F K A P T I D I R P R S A T I Q M N 351 gabrg2 human
V E Y G T L H Y F V S N R K P S K D K D K K K K N P - - - - - - - - A P T I D I R P R S A T I Q M N 350 gabrg2 rat
V E Y G T L H Y F V S N R K P S K D K D K K K K N - - - - - - - - K A P T I D I R P R S A T I Q M N 88 gabrg2 chimp 
V E Y G T L H Y F V S N R K P S K D K D K K K K N P L L R M F S F K A P T I D I R P R S A T I Q M N 351 gabrg2 bovin
V E Y G T L H Y F V S N R K P S K D K D K K K K N P L L R M F S F K A P T I D I R P R S A T I Q M N 350 gabrg2 chick
I E Y G T L H Y F V S N R K P S A K K D K K K K N P                                                 207 gabrg2 pufferfish
I E Y G T L H Y F V S N R K P S A K K D K K K K N P                                                 207 gabrg2 tetraodon
N A T H L Q E R D E E Y G Y E C L D G K D C A S F F C C F E D C R T G A W R H G R I H I R I A K M D Majority
410 420 430 440 450
N A T H L Q E R D E E Y G Y E C L D G K D C A S F F C C F E D C R T G A W R H G R I H I R I A K M D 371 gabrg2 mouse
N A T H L Q E R D E E Y G Y E C L D G K D C A S F F C C F E D C R T G A W R H G R I H I R I A K M D 401 gabrg2 human
N A T H L Q E R D E E Y G Y E C L D G K D C A S F F C C F E D C R T G A W R H G R I H I R I A K M D 392 gabrg2 rat
N A T H L Q E R D E E Y G Y E C L D G K D C A S F F C C F E D C R T G A W R H G R I H I R I A K M D 130 gabrg2 chimp 
N A T H L Q E R D E E Y G Y E C L D G K D C A S F F C C F E D C R T G A W R H G R I H I R I A K M D 401 gabrg2 bovin
N A T H L Q E R D E E Y G Y E C L D G K D C A S F F C C F E D C R T G A W R H G R I H I R I A K M D 400 gabrg2 chick
                                                                                                    232 gabrg2 pufferfish
                                                                                                    232 gabrg2 tetraodon
S Y A R I F F P T A F C L F N L V Y W V S Y L Y L Majority
460 470
S Y A R I F F P T A F C L F N L V Y W V S Y L Y L                                                   421 gabrg2 mouse
S Y A R I F F P T A F C L F N L V Y W V S Y L Y L                                                   451 gabrg2 human
S Y A R I F F P T A F C L F N L V Y W V S Y L Y L                                                   442 gabrg2 rat
S Y A R I F F P T A F C L F N L V Y W V S Y                                                         180 gabrg2 chimp 
S Y A R I F F P T A F C L F N L V Y W V S Y L Y L                                                   451 gabrg2 bovin
S Y A R I F F P T A F C L F N L V Y W V S Y L Y L                                                   450 gabrg2 chick
                                                                                                    232 gabrg2 pufferfish
                                                                                                    232 gabrg2 tetraodon
Decoration 'Decoration #1': Shade (with solid black) residues that match the Consensus exactly.
Cytoplasmic domain (TM3-TM4 Loop)TM3
TM4
Figure 4.2: Aminoacid alignment of cytoplasmic domain (TM3-TM4 loop) of g2 subunit across
vertebrates. The cytoplasmic domain of g2 subunit is highly conserved among the vertebrate
evolution. Although pufferfish and tetraodon species genes have not been sequenced totally to
evaluate this homology more precisely, the partial sequences are significantly similar with the other
species.
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5 APPENDIX
The Appendix contains supplementary material on methods relating to
subcloning of DNA fragments, in vitro mutagenesis
 of plasmids, culture of HEK cells and neurons, and immunodetection of GABAA
receptor subunits expressed in HEK cells.
5.1 Plasmid preparation
Plasmids were isolated from 1.5 ml cultures (minipreps) by alkaline lysis with
SDS according to Protocol 2 given in volume I of Sambrook and Russell, 2001.
For all plasmid preps I used DH5a (Invitrogen) for bacterial transfomation. For
plasmids which were to be transfected into neurons I used maxipreps (QIAfilter
Plasmid Maxi Kit, Qiagen).
5.2 DNA gel electrophoresis
DNA fragments from digested plasmids were separated by electrophoresis on 0.8
to 1.0 % agarose gels (containing 0,5 mg/ml ethidium bromide) in 1 x TAE buffer
(800mM Tris-HCl, 400mM NaOAc, 40mM EDTA, pH 8.3 adjusted with acetic
acid).
5.3 Destroying enzyme sites in plasmids by blunting and religation
1 µg of plasmid (e.g. pRK5GFPg2) (1 mg is typically 1 ml of a standard plasmid
miniprep) was linearized with SalI in 20 µl reaction mixture for 1 h at 37°C and
then blunted using Klenow enzyme (Roche) (10 µl pRK5GFPg2 digestion, 1 mM
each dNTP, 2 µl 10X filling buffer, 1 U Klenow enzyme and H2O up to 20 µl) for
15 min at room temperature. Klenow was heat inactivated at 70°C for 20 min.
The vector was then recircularized: to 8 µl of heat inactivated Klenow mixture, I
added ligation buffer, ATP and T4 ligase; after 4 h at room temperature the
ligation was transformed into DH5a  E. coli cells. Randomly picked colonies
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were minicultured and the isolated plasmid DNA was restricted with SalI,
electrophoriesed in agar gels; supercoiled (i.e. non-cutting) plasmids were
chosen.
5.4 Removing inserts from plasmids by digestion and religation.
1 µg of plasmid (e.g. pRK5GFPg2(Sal)2) (1 mg is typically 1 ml of a standard
plasmid miniprep) was digested with SalI in 20 µl reaction mixture for 1 h at
37°C, and then heat inactivated at 70°C for 20 min. The vector was then
recircularized: to 8 µl of heat inactivated digestion mixture, I added ligation
buffer, ATP and T4 ligase; after 4 h at room temperature the ligation was
transformed into DH5a  E. coli cells. Randomly picked colonies were
minicultured and the isolated plasmid DNA was restricted with SalI,
electrophoriesed in an agar gel, and appropriate plasmids selected by size of
fragment.
5.5 Construction of Thy1 GFP-GABAA receptor subunit expression vectors
The Thy-1.2 expression cassette plasmid (Caroni, 1997) was linearized with
XhoI, which is a unique insertion site downstream of the Thy1 promoter, blunted
with Klenow polymerase, and SmaI-EcoRI adaptors ligated onto this plasmid
linearized backbone, and then EcoRI fragments of GABAA receptor cDNAs
ligated into this to recircularize the plasmid (Wisden et al 2002). In detail, this
was done as follows: 2 ml (2 mg) of Thy1.2 plasmid was linearized with XhoI in a
20 ml digestion volume; 10 ml of this digest was then blunted with Klenow (see
above sections for details on blunting), the Klenow then heat killed at 70oC; 10 ml
of this linearized blunted Thy1 vector was mixed with 6 ml of SmaI-EcoRI
adaptors at 0.4 mg/ml (Stratagene), 2 ml of 10X ligase buffer (plus rATP) and 2 ml
of T4 ligase (NEB) and left at 16oC overnight. The reaction volume was then
increased to 100 ml with TE buffer (0.01 M Tris/0.1 mM EDTA, pH 7.6, sterile)
and then spun through a Chromaspin 1000 TE column (Clontech) to remove the
excess adaptors. To ligate in the EcoRI gel purified GABAA cDNAs, I mixed
5. Appendix
72
10!ml of the column eluate, 20 ml of EcoRI gel pure cDNA insert (see Methods),
70 ml water, 1 ml glycogen stock (as carrier), 10 ml 3 M sodium acetate, and 250
ml 100 % ethanol, followed by spinning, washing the pellet in 70 % ethanol, and
resuspending in 8 ml water, 1 ml 10X ligation buffer (plus rATP) and 1 ml T4
ligase; the reaction was left at 16 °C overnight. The ligation mix was transformed
into DH5a cells, and colonies with inserts selected by colony screening using the
cDNA as a hybridization probe. The correct orientation of inserts was verified by
restriction mapping and confirmed by sequencing with Thy1 primers upstream of
the XhoI site.
5.6 Colony screening protocol for ligations
The TM3-TM4 loop inserts in the pRK5GFPg2 T M 3 - T M 4 d  and
pRK5GFPdTM3-TM4g2 subclones were identified by colony screening of
ligations. Agar plates containing transformed colonies were kept 1 h at 4 °C
before colony lifting. Afterwards, the colonies were lifted on Hybond N+
(Amersham) membranes (after the membranes and plates had been co-marked
with pinholes) and the membranes were transferred (colony side up) for 5 min on
Whatmann paper soaked in 2 x SSC/5% SDS solution for cell lysis (Buluwela et
al., 1989). The filters were then microwaved at high power for 2.5 minutes, so
crosslinking DNA with the membrane (Buluwela et al., 1989). Colony lifted agar
plates were kept 24 hours at room temperature allowing the regrowth of the
colonies for later picking. The membranes were hybridized overnight at 42°C
with 32P-labeled (random-primed) TM3-TM4 g2 or d loop fragment probes (5 ml
of [a-32P]dCTP, Specific activity: 110 TBq/mmol, Radioactive concentration:
370 MBq/ml from Amersham is used for the radiolabeling of DNA probe with
Rediprime II DNA Labelling Kit (Amersham)): briefly, the DNA probe
(approximately 1 mg is diluted 44 ml TE buffer) is denaturated at 95 °C for 5 min
and then kept in ice for 5 minutes and added to the Rediprime labelling kit. After
the addition of radioactive dCTP, the final mixture was mixed with the
micropipette and incubated at 37 °C for one hour. The un-incorparated
oligonucleotides were removed by Chromaspin 100 (1000) TE columns from
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Clontech. After measurement of the degree of radioactive labelling, the probe is
denaturated before the hybridisation (hybridization buffer contained 50%
formamide/5 x SSC). After hybridization, filters were washed once with 2 x SSC
solution at room temperature for 5 min and twice with 0.1 x SSC at 65 °C (for
restriction fragment probes) and 1 x SSC at 60 °C for oligonucleotides (30 to 45
mers); filters hybridized with shorter oligonucleotides were washed with 1 x SSC
at 42 °C. Hybridized filters were exposed 2 h to autoradiographic film
(X-OMAT, Kodak) at -70 °C in cassettes with scintillation screens. Positive
colonies were picked and minicultured; plasmids were isolated and analysed by
restriction enzyme digestion and gel electrophoresis. (1 X SSC: 150 mM NaCl/15
mM NaCitrate).
5.7 In vitro mutagenesis
Site-directed mutagenesis was carried out using oligonucleotides (Invitrogen) and
the Stratagene Quick Change mutagenesis kit, in which oligonucleotides with the
desired mutation are annealed to plasmid DNA to prime in vitro DNA synthesis
with Pfu DNA polymerase, and selection of mutants is done by DpnI digestion.
Briefly, with the use of a thermal re-cycler, complementary primers (each 125
ng) carrying the desired mutation in the middle of (at least) 24-mer
oligonucleotides (with at least 40 % GC content) were allowed to anneal 1
minute at 55-60 ºC to denaturated parental DNA plasmid (5-50 ng of dsDNA
template; usually I used 1-5 µl of a 1:100 diluted miniprep) in a reaction volume
of 50 µl in the presence of dNTPs, Pfu Turbo and reaction buffer as described in
the protocol of the supplier. Then the DNA polymerase (Pfu Turbo, with
proofreading ability) extends and incorporates the mutagenic primers resulting in
nicked circular strands (for 30 seconds at 68 ºC). After several cycles (18 times)
of the same procedure that have been performed in the thermal re-cycler, the
reaction mixture is allowed to cool in ice for a couple of minutes and then at
37!ºC, it is treated with Dpn1, an enzyme that selectively digests the methylated
or parental DNA and thus allowing to isolate the mutated DNA. Enzymatic
digestion were carried out for 1 hour and then the Dpn1 was inactivated at 65 ºC
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for 15 minutes, before subsequent transfomation into competent bacteria
(provided by the mutagenesis kit). The DNA extracted from the colonies was
sequenced to verify mutagenesis.
5.8 In vitro expression of GABAA Receptors in HEK 293 cells
5.8.1 Preparation of plating medium for HEK 293 cells:
The coverslips were washed with 70 % ethanol followed by dry-heat sterilization
in a box between layers of kimwipes. The surface of the coverslips was then
covered with about 300 µl of Fibronectin (5-10 µg/ml) in 24-well plates, before
washing with 1x PBS and letting them dry for half an hour and subsequent
plating the HEK cells.
5.8.2 Plating of HEK 293 cells
Frozen aliquots of Human Embryonic Kidney Cells (i.e., HEK cells, A293;
ATCC CRL 1573) were stored in liquid nitrogen. When needed, they were
thawed quickly in a water bath at 37 °C, transferred into a tube containing warm
medium and spun down at 800 rpm/RT for 5 min. The pellet was re-suspended in
10 ml warm medium and plated onto a 94 mm ∅  dish and cultivated in an
incubator at 37 °C and 5 % CO2. When they reached a suitable density they were
split; after a washing step with 1x PBS to remove dead cells, the remaining cells
were transferred with warm medium into a centrifugation tube to spin them
down. Afterwards they were resuspended in warm medium and plated on 12-or
24-well plates in the desired density. HEK cells were maintained in DMEM
(Gibco) supplemented with 10 % fetal bovine serum. The plates were incubated
at 37 °C and 5 % CO2 until the day of transfection (normally after one day from
the seeding).
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5.8.3 Transfection of HEK 293 cells by Ca3(PO4)2 precipitation
Exponentially growing HEK cells,
seeded at 4 x 104 cells/well/24 well-
plate, were transfected by Ca3(PO4)2
precipitation using equimolar ratios of
expression constructs (Conolly et al.,
1996). The transfection procedure (1ml
for 2 coverslips on 24 well plate and 1
coverslip on 12 well plate) is described
on the Table 5.1. After transfection,
cells were kept at 37 °C, 3 % CO2
incubator overnight, then the medium
was renewed and the cells were transfered to 5 % CO2 incubator. Cells were
analyzed 48 hrs after transfection.
(2x BBS: 50 mM BES (NW 213) Sigma cat. #B-9879, 280 mM NaCl, 1.5 mM
Na2HP04, pH: adjusted to 6.89 with NaOH).
5.9 Immunostaining of HEK 293 cells
A293 cells on Fibronectin coated coverslips were washed with warm PBS two
times and then cells are fixed with cold 4 % PFA for 10 minutes at 4 °C
(coldroom). After two or three washings with cold PBS (described in Methods,
section 2.3) the cells are permeabilized (if desired) in 0.2 % Triton in 1xPBS.
Nonspecific binding of the first antibody was eliminated by blocking in the cells
with 4% NGS in the presence of 0.2 % Triton in PBS for 30 min. The primary
antibody was applied in recommended dilution (anti-green fluorescent protein
rabbit serum, 1:10000 dilution, Molecular Probes, USA), in (0.1% Triton, 4 %
NGS) PBS and for at least two hours at RT, or over night. Afterwards cells were
washed twice in PBS. The secondary antibody (CY-3 anti-rabbit, Jackson
Laboratories) was applied  in 1.5 % NGS for 1-2 hours at room temperature
before washing again two times with PBS and a final washing step in water, the
coverslips were mounted on slices for microscopy with Mowiol.
Ingredients per1 ml culture
Plasmids
(200 ng /ml)
6 ml
H2O 37.75 ml
CaCl2 (2M) 6.25 ml
2 x BBS 50 ml
vortex and
wait 80-90 seconds…
Medium
DMEM (Gibco)
0.9 ml
Table 5.1: Transfection protocol for HEK
cells
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5.10 Immunoprecipitation and Western Blot of Protein Extracts from HEK
cells
5.10.1 Preparation of cell lysates
Transfected HEK cells in 90 cm dishes were maintained for 2 days in the
appropriate incubator, then the cells were washed with 5 ml PBS (warm) once,
before the harvesting of cells with 1 ml of chilled Lysis Buffer (25 mM HEPES,
150 mM NaCl, pH 7.4, 1 % Triton (w/v)) including Protease inhibitor cocktail
tablet (Roche). The cells were collected in prechilled 1 ml reaction tubes and
incubated at 4 °C on an overhead shaker for at least half an hour before
centrifugation at full speed on a table-top centrifuge for 10 minutes at 4 °C. The
supernatant was collected in to clean cold eppendorf tubes and the pellet was
discarded. (The supernatant could be stored at –80 ºC at this step for future use.)
5.10.2 Immunoprecipitation
5.10.2.1 Preclearing of cell lysate
20 m l of washed protein A slurry (approximately 50 ml of protein A slurry
washed 2 times with 800 ml of cold 0.1 % Triton, 25 mM Hepes, 150 mM NaCl
pH 7.4, including protease inhibitor cocktail, each time spinned at 2500 rpm for
1 min at 4 ºC on a table top centrifuge, the beads were collected by sterile
micropipette tips cut from the tip-end) was added to 950-1000 ml of cell lysate
and incubated for 30 minutes at overhead-shaker at cold room before spinning
them at 14000 rpm for 10 minutes at 4 ºC.
5.10.2.2 Protein-Antibody Coupling
1.5 mg of anti-GFP antibody (Anti-AFP mAb 3E6, AFP 5002, Qbiogene Inc.)
was added to each supernatant obtained from the previous step containing cold
precleared lysates (around 800 ml) and incubated for 2-3 hours (or overnight) at
4 °C at overhead-shaker.
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5.10.2.3 Protein A-Antibody Coupling
After the protein antibody coupling in the previous step, 20 ml of pre-washed
protein A slurry (Protein A Agarose, Fast Flow, 50 % v/v, P3476-5ML, Sigma)
was added to each sample and incubated 1 hour at 4 ºC, overhead shaker. The
samples were spun at 2500 rpm for 1 min at 4 ºC; and washed three times with
chilled HEPES buffer containing 0.1 % Triton (w/v), 25 mM HEPES; 150 mM
NaCl, pH 7.4 with protease inhibitor cocktail (Roche). Elution was achieved by
adding appropriate amount of loading buffer i.e., 20 ml of 2x loading buffer (for
western blot) and boiling the samples at 95 ºC for 5 min. The samples were spun
for 1 minute on a table top centrifuge before loading on the SDS-PAGE gel.
5.10.3 Western blot
The gels were applied 120 Volts for stacking gel and at 140 Volts for resolving
gel at RT, for about 1_ hours with 1x Running Buffer (10X Running Buffer
Stock: 30.3g. Tris; 144g Glycine; 10g SDS dissolved in 1 liter distilled H2O, pH
8.3).
4 % Stacking Gel  10 % Resolving Gel
DDI H2O (ml) 6.1 4.1
30 % Degassed
Acrylamide/Bis(ml)
1.3 3.3
Gel buffer* (ml) 2.5 2.5
10 % w/v SDS (ml) 0.1 0.1
TEMED (µl) 12 9
10 % (w/v) APS (µl) 100 80
Table 5.2: Ingredients of the acrylamide gels for PAGE. *Stacking Gel Buffer:
0.5 M Tris-HCl, pH 6.8. *Resolving Gel Buffer: 1.5 M Tris-HCl, pH 8.8
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Blotting:
The gel slabs were removed from the glass blocks carefully and assembled in to
transfer apparatus for protein transfer to membranes (Hybond-P, Amersham,
UK); which were pre-soaked in methanol and then in running buffer (as
described in the user manual) before setting up the blot. Transfer was achieved at
90 mA over night at room temperature with Transfer Buffer: 100 ml methanol,
800 ml H2O, 100 ml of 10x Transfer buffer (10 X stock: 30.3 g Tris, 144 g
Glycine dissolved in 1 liter distilled water).
Blocking:
20 ml of blocking solution was used per membrane at least 30 minutes at room
temperature, shaking.
Blocking solution: 10 % Milk (w/v) in 0.05 % PBST
20 gr milk powder
1 ml of 10 % PBST (10 % Tween (Sigma) v/v in PBS -137 mM NaCl, 2.7 mM
KCl, 8 mM Na2HPO4, and 2 mM KH2PO4, pH 7.4)
final volume 200 ml PBS
Primary Antibody:
GFP Ab (Anti-green fluorescent protein rabbit serum; Molecular Probes, USA),
1:10000 dilution, in 8 ml of 0.05 % PBST, incubated at room temperature with
shaking at 35 rpm for 2 hours. Then the membranes were washed 3 times for 5
minutes with at least 10 ml of 0.05 % PBST, at room temperature 40 rpm.
Secondary Antibody:
1:20000 diluted peroxidase labelled anti-rabbit IgG (Vector Laboratories, CA)
in 8 ml 0.05 % PBST, 1 hour at room temperature, shaking at 35 rpm, then
washed three times as before.
The membranes were treated with 1 ml ECL plus Western Blot Detection System
(Amersham, UK) reagent for maximum 5 minutes and then exposed appropriate
time duration for development of the films.
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5.11 Expression of d and g2 GABAA Receptor Subunit Chimeras in HEK
cells
5.11.1 Chimeric d and g2 cDNAs are translated into protein without
truncation
HEK cells were transfected with CMV-promoter-based expression plasmids of
the GABAA receptor subunits; to ensure stable receptor expression, I co-
transfected cells with a1 and b2 subunit cDNA expression plamids in addition
to the test subunit (i.e. triple transfections). GFP expression was detectable for
all subunits during live cell fluorescence imaging (data not shown). Transfected
HEK cells also stained strongly with a GFP-specific-antibody (see section
below). However, western blot analysis of HEK cell extracts transfected with
chimeric GABAA receptor cDNAs did not reveal any bands of the expected
size; note that a high amount of immuno-positive aggregated protein was visible
on top of the gel in each case. But after immunoprecipitation of HEK cell
extracts with GFP antibody, the staining of immunoblot against GFP gave
signals in the size range of GFP g2 or GFPd and chimeric receptors (Figures 5.1a,
and b, Figure 5.2). The native murine g2 subunit has a size of 55 kDa and native
d subunit has a size about 50 kDa and GFP is 25 kDa. Therefore chimeric GFPg2
is 80 kDa and GFPg2TM3-TM4d is 83 kDa, GFPd is 75 kDa and GFPdTM3-TM4g2
is 77 kDa.
5. Appendix
80
a) GFP Immunoreactivity of protein extracts from HEK cells transfected
with GFPg2 or GFPg2d cDNAs
Figure 5.1: Immunoblotting of HEK cell protein extracts obtained after transfection of HEK cells
with cDNAs of GFPg2 and GFPg2TM3-TM4d. GFP immunoreactivity (shown by red arrowhead for
the GFPg2d and red arrow for GFPg2 signals) is shown in a and g2 (specific for TM3-TM4 loop)
immunoreactivity (shown by red arrow) is shown in b. Protein extracts obtained from transfected
or untransfected HEK cell lysates (negative control) were loaded to SDS-PAGE gels for
immunoblotting directly after protein extraction (input protein) or after immunoprecipitation with
GFP antibody (immununoprecipitation), the supernatant from immuno-precipitated samples were
also loaded (supernatant).
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b) GFP immunoreactivity of protein extracts from HEK cells transfected
withGFPd and GFPdTM3-TM4g2
Figure 5.2. Immunoblotting of HEK cell protein extracts obtained after transfection of HEK cells
with GFPd and GFPdTM3-TM4g2 chimeric cDNAs. Cells transfected with cDNAs of GFPg2, and
GFPg2TM3-TM4d were used as positive controls. Protein extracts obtained from transfected or
untransfected HEK cell lysates (negative control) were loaded to SDS-PAGE gels for
immunoblotting directly after protein extraction (input protein) or after immunoprecipitation with
GFP antibody (immununoprecipitation).
5.11.2 Chimeric GABAA receptors are targeted to the cell surface of HEK
cells
To check the expression and membrane targeting of chimeric g2 and d GFP-
tagged GABAA subunits, transfected HEK cells were stained with a GFP-selective
antibody and examined under the laser scanning confocal microscope. In Figures
5.3A and B, staining with the GFP antibody in unpermealized conditions for
cultured HEK cells transfected with g2 and g2d (in the presence of a1 and b2) is
shown. The surface membrane-targeted receptors are visible in red, the internal
GFP expression is detected as green, which may correspond to synthesized
subunits not targeted to the membrane, or that are in the process of being
transported (or removed) to/from the outer membrane.
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Similarly, in vitro expression of the GFPd  or GFPdTM3-TM4g2  subunits in the
presence of a1 and
b 2 subunit gave
GFP
immunoreactivity as
shown by red color
i n  t he  ou t e r
membrane (cel l
surface) as well as
internal receptors
shown by green
color (Figures 5.3C
and D).
5.12 Primary cell culture of neurons
Primary cultures of neurons are prepared according to Choi et al. (1987) with
some modifications. Briefly, hippocampal cells from each individual mouse
embryos (E-16) were dissociated and plated with a density of 40.000 on poly-L-
Lysine coated coverslips (300 ml of 5 mg/ml per coverslip) in 24 well plates.
Cultures were kept at 37 °C in a 5 % CO2 incubator. The cultures were fed 24
hours after plating and the medium was changed every four days. During feeding,
A
C D
B
*
*
*
*
 *
Figure 5.3: Expression of chimeric constructs in HEK cells.
Scanning confocal images of fixed and immunostained cells
transfected with GFPg2 (A), GFPg2TM3-TM4d (B), GFPd (C),
GFPdTM3-TM4g2 (D), in the presence of a1 and b2 subunits
of GABAA receptors show that chimeric receptors (red), are
targeted to plasma membrane as shown by white arrows
while some of the receptors also restricted in the endoplasmic
reticulum as shown by “*”, (green). (Scale bar: 15 mm)
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the culture medium was never changed completely, except for first exchange of
the medium with FDX to prevent glial cells overgrowing. Later, for each feeding
only half of the medium was replaced. Cells were transfected at DIV7 and used
for experiments at DIV19.
1x PBS without Calcium amd
magnesium, sterile filtered
PAA Laboratories GmBH, H15-002
PBS/HEPES/Glucose, pH 7.38
100 ml 10x PBS
6 g D-(+)-Glucose
7.38 g HEPES
Gibco, 14200-067
Sigma, G-7021
Roth, 9105-2
adjust the pH to 7.38 with 2N NaOH
Culture Medium:
500 ml Neurobasal Medium without L-
glutamine
10 ml B-27 Supplement (50x)
1.25 ml L-glutamine
5 ml Penicillin-Streptomycin
(0.2M)Penicillin-Streptomycin
Gibco, 21103-049
Gibco, 17504-044
Gibco, 25030-024
Gibco, 15140-114
0.25 % Trypsin in PBS w/o Calcium &
Magnesium sterile filtered
PAA, L11-002
Poly-D-Lysine Hydrobromide 1mg/ml Sigma, p-1149
Table 5.3 Specific Reagents and Solutions used for the cell culture
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5.13 Accession numbers of peptides for GABAA receptor subunits
Species Database Accession #
Mus musclulus (mouse) NCBI protein database NP_803127
Homo sapiens (human) NCBI protein database NP_944494
Rattus novergicus (rat) NCBI protein database P18508
Pan troglodytes (chimpanzee) ENSEMBL genomic database ENSPTRP00000045735*
Bos taurus (cow) NCBI protein database P22300
Gallus gallus (chick) ENSEMBL genomic database P21548
Fugu rubripes (pufferfish) ENSEMBL genomic database NEWSINFRUP00000159131*
Tetraodon nigroviridis ENSEMBL genomic database GSTENT00033745001*
Table 5.4 Peptides used in the g2 subunit cytoplasmic domain (TM3-TM4 loop) alignment *:
Non-annotated, partial genomic sequence
Species Database Accession #
Mus musclulus (mouse) NCBI protein database AAL37410
Homo sapiens (human) NCBI protein database AAB70007
Rattus novergicus (rat) NCBI protein database AAH87714
Pan troglodytes (chimpanzee) NCBI genomic
database
NW_101530.1*
Bos taurus (cow) NCBI protein database XP-585530
Canis familiaris (dog) NCBI protein database XP-857845
Sus sucrofa (pig) NCBI protein database CAI61946
Danio rerio (zebrafish) ENSEMBL genomic
database
XP_70009.1*
Gallus gallus (chicken) ENSEMBL genomic
database
NP_032098.01*
Contig52.113
Table.5.5 Peptides used in the d subunit cytoplasmic domain (TM3-TM4 loop) alignment. *:
Non-annotated, partial genomic sequence
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6 ABBREVIATIONS
Å Ångstrom (10-10 m)
a32P-dCTP deoxycytosine triphosphate labelled with 32P in alpha
position
g2L long isoform (splice variant) of gamma 2 subunit of
GABAA receptors
AMPA alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic
acid
APS ammonium persulphate
BDNF brain derived neurotrophic factor
BLAST basic local alignment search tool
bp base pair
BSA bovine serum albumin
BZ benzodiazepine
cDNA complementary DNA
Cl- chloride
CNS central nervous system
Cys cysteine
D aspartic acid
DDI double distilled
DNA deoxyribonucleic acid
dNTP deoxyribonucleotide triphosphate
EC50 effective concentration of an agent required for 50%
desired effect on the ion channel site
em electron microscopy
EDTA ethylenediamine tetraacetic acid
EGFP enhanced green fluorescence protein
6. Abbreviations
86
F phenylalanine
GABA g-aminobutyric acid
GAD 67 glutamic acid decarboxylase enzyme isoform
GABAARs g-aminobutyric acid type A receptors
GFP in this study GFP refers to EGFP
GlyRs glycine receptors
GODZ golgi-specific DHHC zinc finger protein
H histidine
5HT 5-hydroxytryptamine
HEK human embryonic kidney
HEPES N-(2-Hydroxyethyl)piperazine-N’-ethanesulfonic acid
IC50 Inhibition concentration of an agent required for 50 %
inhibition of ion channel site
IgG immunoglobulin G
IPSC inhibitory postsynaptic current
K lysine
KO knock out
L leucine
Lys lysine
mM milli molar
M Molar
M methionine
mRNA messenger RNA
nACHRs nicotinic acetylcholine receptors
NGS normal goat serum
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NMDA N-methyl-D-aspartate
ORF open reading frame
PAGE polyacrylamide gel electrophoresis
PBS phosphate buffered saline
PBST tween/phosphate buffered saline
PCR poymerase chain reaction
PDZ domain postsynaptic density/disc large/zona occludens-1
homology domain
PFA paraformaldehyde
PKA cyclic AMP-dependent protein kinase A
PKC protein kinase C
PSD postsynaptic density
R arginine
RNA ribonucleic acid
RT room temperature
RT-PCR reverse transcription coupled to polymerase chain
reaction
S serine
SDS sodium dodecyl sulphate
SEM standard error of the mean
SSC standard saline citrate
SSRI selective serotonon re-uptake inhibitor
SDS-PAGE denaturating polyacrylamide gel electrophoresis
T threonine
TBLASTN translating BLAST
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TE tris/EDTA buffer
TM transmembrane
TEMED N, N, N‘, N‘-tetramethyl-ethylendiamine
Tris tris-(hydroxymethyl)-aminomethane
TrKB tyrosine kinase receptor b
U unit
X degenerate aminoacid residue
V valine
Y tyrosine
Zn 2+ zinc
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